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Abstract 
Base pairing small regulatory RNAs (sRNAs) are important post-transcriptional 
regulators of gene expression in bacteria. These sRNAs deploy novel mechanisms to 
regulate mRNA targets leading to various physiological outcomes during stress 
conditions including, but not limited to, iron starvation, carbon flux and metabolism, 
virulence, and quorum sensing.  In this study, we investigate the multitude of clever 
mechanisms that two sRNAs, SgrS and DicF, utilize to regulate gene expression, and the 
physiological consequences of such regulation.   
The SgrS sRNA participates in a response to a growth inhibitory stress condition 
called sugar-phosphate stress caused by the toxic accumulation of phosphorylated sugars.  
SgrS combats this stress with its RNA base pairing function by silencing translation of 
sugar transporters that import the stress molecules.  SgrS was previously shown to 
negatively regulate the manXYZ broad sugar-substrate transporter.  In this study we 
demonstrate that SgrS binds at manX and in the intergenic region of manXY to 
translationally silence this operon.  We show that pairing at both these sites is critical for 
degradation of the manXYZ polycistron, and is also crucial for providing maximal relief 
from stress.  SgrS is a dual-function sRNA in that in addition to its RNA function, it also 
produces a peptide called SgrT.  Here, we investigate the mechanistic relationship 
between these two functions of SgrS.  We demonstrate that while mutating the sgrT 
translation initiation sequences have little impact on SgrS base pairing properties, 
mutations in the sgrS base pairing region increase SgrT production.  Further, the SgrS 
RNA function was the primary means of action against sugar-phosphate stress; SgrT 
production lags SgrS synthesis.  We therefore propose a model in which the two 
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independent functions of SgrS act at different stages in response to sugar-phosphate 
stress.   
 The DicF sRNA is encoded on the dicBF operon on the cryptic Qin prophage in 
E. coli.  The only known target of DicF is the ftsZ mRNA, whose gene product is 
essential for cell division in bacteria.  Using reporter gene fusions to predicted target 
genes, we identified three genes in metabolism that are also targets of DicF.  DicF also 
requires core E. coli proteins for its base pairing properties.  We also demonstrate that in 
addition to inhibiting cell division, DicF leads to growth inhibition of cells.  Lastly, the 
gene products of the dicBF operon are cumulatively toxic to E. coli cells.   Characterizing 
mechanistic contributions of sRNAs to significant physiological outcomes will better our 
understanding of these novel regulatory RNA elements.  
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Chapter 1: Introduction 
 1.1. RNA regulators 
 In 1958, Francis Crick coined the term “central dogma” to indicate the relay of 
genetic information encoded by genes.  In the traditional sense, the central dogma states 
that genetic information is coded in DNA, which is then transcribed into a messenger 
RNA (mRNA) template, which in turn is translated to make protein molecules.  In this 
classic view, proteins with catalytic activities are end products and the ultimate regulators 
of gene expression in bacterial and eukaryotic cells.   
 This traditional view was altered in the 1980s and later, when some precursors of 
proteins, i.e., RNA molecules, were determined to have regulatory roles.  Instead of their 
conventional protein coding, mRNA function, some RNA molecules seemed to regulate 
expression of genes or could even alter the functionality of some proteins.  Soon, 
regulatory RNAs were found to play a variety of biological roles across all three domains 
of life.  Identification of these molecules is a more recent phenomenon in archaea, while 
regulatory RNAs are more established in eukaryotes and bacteria.   
1.1.1. Regulatory RNAs in eukaryotes 
Eukaryotic regulatory RNAs are ~20-200 nt in length and are largely non-coding.  
These regulatory RNAs can be generally classified as microRNAs (miRNAs) or small 
interfering RNAs (siRNAs).  They regulate a variety of cellular processes ranging from 
development and cell proliferation to metabolism and immunity [55]. 
 History: The first and founding member of the miRNA family was found in C. 
elegans by Ambros and group  [71] This miRNA, called lin-4, was identified through a 
genetic screen seeking to discover mutations that disrupt temporal development in the 
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different larval stages of C. elegans [71].  The discovery of this famous RNA regulator 
brought about an explosive discovery of miRNAs in the following years.  By 2001, 
miRNAs were identified in various eukaryotic cells; at least, dozens of miRNAs were 
found in several animal and plant species.   
During the discovery of lin-4, RNA interference and silencing was believed to 
only be carried out by single-stranded RNA (as in miRNAs).  However, in 1995, Guo and 
Kemphuous discovered that exogenous double-stranded RNA (dsRNA) also possesses 
mRNA silencing capabilities [49].  Later, Fire, et.al demonstrated that one particular 
exogeneous dsRNA was more potent in silencing gene expression than either strand 
alone, implying the existence of a different type of RNA regulator molecule than 
miRNAs [36].  Shortly thereafter, these 21-23nt RNA molecules were termed siRNAs 
[20].   
While miRNAs and siRNAs are both short RNA molecules with regulatory 
functions, their induction and cellular roles seem to be different.  miRNAs are primarily 
regulators of endogenous gene expression, while siRNAs are produced in response to 
invasive nucleic acids such as viruses and transposons [20].  Nevertheless, both these 
RNA regulators act to regulate gene expression post-transcriptionally.  They act by a base 
pairing mechanism either with perfect or imperfect complementarity to the target 
transcript and thus regulate their expression.  
 Types of regulatory RNAs: Various RNA regulators are produced in eukaryotes.  
Some salient features of two major types of regulatory RNAs are discussed below.  
 MicroRNAs (miRNAs): miRNAs are produced in both the plant and animal 
kingdom of Eukaryota.  They are initially transcribed as a pri-miRNA of about 33nt in 
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length, and then are processed into smaller 22nt RNAs in the nucleus and in the 
cytoplasm [20].  In animals, these single-stranded RNAs then act on target mRNAs by 
binding at their 3′ untranslated region (UTR) with imperfect complementarity via 
Watson-Crick base pairing.  Multiple miRNAs bind at the 3′ UTR, leading to 
translational silencing and degradation of the target mRNA.  Whether these miRNAs 
inhibit  translation initiation or act at some other phase of translation is still unclear [20].  
A majority of miRNAs produced in animals have been shown to solely repress translation 
of their targets, without affecting the stability of the message [51].  In contrast, miRNAs 
in plants base pair with near perfect complementarity to target 3′ UTRs, and mostly result 
in degradation of target mRNAs by recruiting the RNA-induced silencing complexes 
(RISC) processing machinery of the cell [51].  
 Small Interfering RNAs (siRNAs): Originally classified as exogenous RNA 
molecules, siRNAs are now also considered to be produced from various animal and 
plant genomes [45].  These RNA molecules are synthesized as 21-25 nt double-stranded 
RNA molecules.  Their biogenesis follows a similar path to synthesis of miRNAs.  After 
the double-stranded RNA is unwound, a single RNA strand associates with RISC, base 
pairs to target mRNAs as a perfect duplex at one site, and mediates direct, RISC-
dependent cleavage of the mRNA at the complementation site [51].  siRNAs are believed 
to be crucial in maintaining genome integrity, as they defend the cell against incoming 
viral particles, transposons and other exogenous nucleic acids [20].   
1.1.2. Bacterial regulatory RNAs (small RNAs) 
Unlike most eukaryotic genomes, in which only 10% of the genome code for 
proteins [41], bacterial genomes have traditionally been considered “simpler” due to their 
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larger fraction of protein coding genes [41].  Therefore, non-coding regulatory RNAs 
were not associated with bacterial transcriptomes for a long time [41].   
 History and identification of small RNAs: The discovery of small regulatory 
RNAs (sRNAs) in bacteria had initially been difficult perhaps due to employment of 
traditional genetic approaches in finding regulators of genes of interest.  Most protein 
regulators in bacteria have been identified by a mutagenesis approach, in which the 
introduction of mutations in regulatory proteins abrogate regulation of a particular gene 
[47].  These classical approaches failed to identify sRNAs because genes encoding these 
RNAs  are a smaller target size for mutagenesis, are often resistant to single-nucleotide 
inactivation mutations and are usually expressed only under certain conditions [47].   
The first few chromosomally-encoded sRNAs in E. coli were identified by 
metabolic profiling of labelled cellular RNAs that were fractionated using various 
methods [57].  This procedure often led to the discovery of RNAs that were part of the 
translational machinery (tRNAs, for example) [47, 57].  On occasion, sRNAs were found.  
The sRNAs Spot 42 (that acts via a base pairing mechanism) and the 6S RNA (that alters 
RNA polymerase activity) were detected in this manner [57, 58].  sRNAs were also 
discovered fortuitously in the 1980s by observations of phenotypes conferred by their 
expression from multi-copy plasmids.  The MicF sRNA that regulates an outer membrane 
protein [89] and the DicF sRNA that leads to inhibition of cell division[13] were products 
of serendipitous discovery.  In the late 1990s, more active approaches were undertaken to 
finding sRNAs.  One such approach was using computational programs to predict the 
existence of gene sequences that contain orphan promoters and Rho independent 
terminators.  Specifically, these programs were designed to search for the presence of 
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sRNA genes in intergenic regions of genomes [3, 24, 121].  Another approach undertaken 
to identify sRNAs was based on the finding that the RNA chaperone Hfq bound with 
high affinity to sRNAs in E. coli and Salmonella [159].  Zhang and group conducted a 
co-immunoprecipitation assay to isolate RNAs that associate with Hfq and identified 
various sRNAs in this manner [159].  
Perhaps the most successful strategies in sRNA identification began in 2001 with 
the usage of whole genome transcriptomics.  Two such approaches, tiling microarrays 
and RNA-Seq analyses, have significantly expanded the identification of sRNAs and 
their targets in various bacterial species [125, 143].  Microarrays, also known as tiling 
arrays, involves the use of thousands of oligonucleotides that systematically cover both 
the sense and antisense strands of the genome [125].  sRNAs expressed from the genome 
is thus detected under specific environmental conditions.  In addition, microarrays 
performed with sRNA overexpression are commonly used to identify targets of sRNAs.  
With the emergence of affordable next generation sequencing technologies, RNA-
Seq methods are now extensively used to find both novel sRNAs in several organisms 
and mRNA targets of sRNAs.  RNA-Seq is a method used to sequence steady-state RNA 
levels in samples that are either treated with different conditions or are genotypically 
different than wild-type [129].  They provide single resolution base pair maps of the 
transcriptome.   
 With the discovery of the abundance of sRNAs produced in several bacterial 
genomes, it is increasingly clear that bacterial genomes are unexpectedly complex and 
produce a variety of RNA regulatory molecules.   
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 Types of small RNAs: Similar to regulatory RNAs in eukaryotes, bacterial sRNAs 
can also be functionally classified into subcategories.  Some sRNAs can modulate protein 
activity by directly binding to proteins and altering their activity. These sRNAs are 
reviewed extensively elsewhere [48, 130, 153].  Others regulate gene expression similarly 
to miRNAs and siRNAs in that they bind to mRNA targets by Watson-Crick pairing, thus 
regulating target expression post-transcriptionally.  The more recently discovered 
CRISPR RNAs are examples of base pairing sRNAs that seem to confer immunity 
against phage infection by recognizing phage particles from previous infections [10, 62].  
In this study, different types of base pairing sRNAs are discussed in detail.   
 Cis-encoded sRNAs: Cis-encoded sRNAs greatly vary in length, ranging from 
100nt to 3500nt.  As the name suggests, these sRNAs are encoded from the antisense 
strand of a known transcriptional unit.  They can be encoded on the 5′ UTR, 3′ UTR or 
can be located within an open reading frame (ORF) [41].  Because these transcripts are 
cis-encoded, they have perfect complementarity to their target mRNA.  Duplex formation 
between the sRNA and the target leads to alterations in secondary structures, resulting in 
ribosome occlusion and silencing of translation (if pairing overlaps the translation 
initiation region (TIR) of the target mRNA).  Following translational inhibition, 
degradation of both the mRNA and the sRNA can take place due to recruitment of the 
cell’s degradation machinery [41].  Some cis-encoded sRNAs also positively regulate 
their targets by aiding formation of a stabilized mRNA due to the pairing [99].  Cis-
encoded sRNAs are major players in toxin-antitoxin systems, in which the antitoxin 
(sRNA) often keeps the production of the toxin (target) in check by regulating its 
expression under  different environmental conditions [153].  
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A novel class of cis-encoded sRNAs are riboswitches [124].  Riboswitches are 
structural elements in the RNA that are formed in cis to the target gene they regulate.  
These cis-acting gene regulatory elements are thought to alter conformation depending on 
the ligands (such as vitamins, flavin molecules, amino acids and purines) they bind [124].  
Their mode of action commonly involves both transcription attenuation and inhibition of 
translation [87, 88, 155] 
 Trans-encoded sRNAs: In contrast to the afore-mentioned sRNAs, trans-encoded 
base pairing RNA molecules are shorter in length, in the 50-250 nt range.  This class of 
sRNAs are perhaps the most abundant and well-studied.  Unlike cis-encoded sRNAs, 
these molecues often have limited complementarity to targets, as they are encoded in 
trans to the genes they regulate.  As a consequence of this imperfect duplex formation, 
they can regulate gene expression of multiple targets [153].  Therefore, to achieve target 
specificity, they require accessory protein chaperones to pair with intended targets.  
Mechanisms by which this class of sRNAs regulate their targets are described in detail in 
1.1.2. Trans-acting sRNAs have been extensively studied in the past decade and have 
been firmly established as critical regulators of gene expression in bacteria.  
 Dual-function sRNAs: Regulatory RNAs, until recently, were primarily 
considered antisense RNAs that solely regulate targets by a base pairing mechanism.  In 
the last several years, it has become increasingly clear that some base pairing sRNAs also 
encode regulatory proteins, and therefore have dual functions [141].  This class of sRNAs 
seem to be on the lengthier end of the sRNA size spectrum, perhaps owing to their two 
functions.  Currently, five dual-function sRNAs are known, and all five of them are >200 
nt in length [141].  A more recently discovered bifunctional sRNA, McaS, has a novel 
8 
 
second function.  It does not encode a peptide, but instead binds and titrates proteins in 
addition to its base pairing function [60].  The functions of the RNA and the protein 
encoded by bifunctional sRNA are highly variable.  Sometimes, peptides encoded by 
dual-function sRNAs participate in the same stress response pathway as the RNA.  For 
example, the bifunctional RNA SgrS in E. coli encodes the peptide SgrT.  Both these 
regulators help rescue cells from glucose-phosphate stress (a bacteriostatic condition 
caused by accumulation of sugar-phosphates) [141, 146].  In contrast, functions of some 
proteins encoded by bifunctional sRNAs are completely unrelated to the function of their 
RNA partners.  The sRNA SR1 produced in B. subtilis encodes the peptide, SR1P.  The 
RNA and protein functions regulate different targets and might function independently of 
one another [42, 52].  While the non-coding, base pairing sRNA mechanisms have been 
studied extensively, much remains to be learned about dual-function sRNA regulators.  
For instance, the molecular functions of the proteins encoded by bifunctional sRNAs and 
the roles of these small proteins in cellular physiology are not well understood.  
Moreover, the interplay between the translation and base pairing activity has not been 
characterized for any dual-function sRNA [141]. 
 Role of accessory proteins in sRNA-dependent regulation:  Interactions between 
trans-acting sRNAs and targets are often mediated by accessory proteins.  Two crucial 
proteins involved in majority of sRNA-target interactions in E. coli and Salmonella are 
described in detail below.  
 Hfq: Hfq (host factor necessary for phage Qβ replication) is a 11 kDa protein, that 
was first identified as a protein required for replication of the bacteriophage Qβ.  Hfq 
homologues were subsequently identified in many different enterobacterial species [14].  
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In E. coli, Hfq is highly expressed and is present in 50-60,000 copies per cell.  Although 
hfq is not an essential gene in E. coli, deletion of hfq has pleiotropic effects.  Cells 
lacking hfq have altered growth rates, are more susceptible to ultraviolet light and 
chemical mutagens, and have elongated cell morphology [14].   
One of the first studies demonstrating the role of Hfq in small RNA stability and 
in post-transcriptional regulation was during the study of the OxyS sRNA [158].  In this 
study, OxyS was shown to regulate expression of the stationary phase sigma factor, 
RpoS, in an Hfq-dependent manner.  OxyS was also directly shown to bind to Hfq by 
electromobility gel shift assays [158].  Since this discovery, many sRNAs in E. coli and 
related enteric organisms have now been shown to associate with Hfq.  Moreover, Hfq is 
essential for the function of several sRNAs [53, 54, 144, 151].  It enables sRNA-mediated 
post-transcriptional regulation of genes by stabilizing the sRNA [70, 90] and by 
promoting sRNA:target RNA interactions [70].  The Hfq protein exists as a hexameric 
complex, forming a ring-like structure in vivo [148].  The published crystal structure of 
Hfq indicates two regions of Hfq, each with distinct affinities to specific RNA substrates.  
The proximal face of Hfq interacts with sRNAs, specifically binding the uracil-rich 
regions.  In contrast, the distal side of Hfq binds target mRNAs [148].  Its exact roles in 
promoting sRNA-mRNA interactions are still unclear.  One hypothesis is that Hfq 
increases local concentrations of both the sRNA and the mRNA, thereby facilitating 
interactions [28].  Another possibility is that Hfq remodels structures of both the sRNA 
and the mRNA such that they attain favorable conformations to interact [28]. 
Interestingly, Hfq is not found in gram positive bacteria, and is dispensable for 
sRNA-mediated regulation in some gram-negative bacteria.  For instance, Hfq is required 
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for the regulatory activity of the RyhB sRNA in E. coli [82], but the equivalent sRNA 
(Nrrf) produced in Neisseria meningitidis does not require Hfq for regulation of at least 
one of its targets [85], even though a functional Hfq is produced in this organism.  This 
raises the possibility of a Hfq-like protein in organisms other than E. coli and Salmonella 
species that is functionally equivalent to Hfq.   
 RNase E and the degradosome complex: One consequence of sRNA-mediated 
regulation is silencing of target translation.  In addition to repression of translation, 
sRNAs (both cis- and trans-encoded) can also lead to degradation of the target mRNA 
[113].  Often, in this process, the sRNA itself is also degraded [94-96, 113].  In E. coli, 
the endoribonuclease, RNase E, and the components of the degradosome play a major 
role in degradation of the sRNA-mRNA complex.  The degradosome, at the minimum, 
consists of several proteins, including the DEAD box RNA helicase (RhlB), a 3′ 
exoribonuclease (PNPase) and the glycolytic enzyme, enolase [46]. RNase E is an 
essential enzyme in E. coli and several other bacterial species.  It plays an active role in 
mRNA, ribosomal RNA and tRNA processing and maturation [75].  
The first report of the role of RNase E in sRNA-mediated decay of targets was 
shown for the RyhB sRNA.  This sRNA participates in the stress response pathway 
induced by iron-starvation conditions [81].  RyhB was initially shown to induce 
degradation of its target sodB in an RNase E-dependent manner [82].  Following this 
report, many sRNA regulators in E. coli have been shown to recruit RNase E and the 
degradosome complex to negatively regulate gene expression [38, 96, 122].  
RNase E exists as tetramers in vivo.  The N-terminal domain of RNase E 
possesses catalytic properties and is required for RNA processing.  The C-terminus of 
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this protein associates with the macromolecules of the degradosome.  It contains binding 
sites for PNPase, RhlB and enolase, thereby impacting assembly of the macromolecular 
degradosome machinery [75].  Degradation of the sRNA-mRNA complex occurs first by 
endonucleolytic cleavage of the sRNA:mRNA complex by RNase E.  Following this 
processing event, PNPase degrades RNA further by its exonucleolytic activity.  The 
helicase, RhlB, is postulated to help unwind RNA structures during the decay process, 
leading to a step-wise degradation of the sRNA:mRNA complex [28].  The role of 
enolase in this process is currently unknown.   
Hfq and RNase E act as accessory proteins in promoting sRNA-mRNA 
interactions.  Since these two proteins perform two distinct functions, they were 
originally thought to act independently.  However, a study by Aiba and group showed 
that Hfq is required for the recruitment of RNase E to the sRNA-mRNA complex, at least 
in the case of one sRNA [96].  Thus, these accessory proteins are not only crucial for 
sRNA-target interactions, but they may also be functioning as large macromolecular 
complexes to achieve target gene regulation.   
 Mechanisms of sRNA-mediated gene regulation: Trans-encoded base pairing 
sRNAs post-transcriptionally regulate target gene expression by a variety of mechanisms.  
The canonical mechanisms and outcomes of sRNA-mediated regulation of gene 
expression are illustrated in Fig. 1.1.  In general, sRNAs can positively or negatively 
regulate expression of target genes.  
Activation of target mRNA translation is typically achieved by sRNA base 
pairing to sequences in the target secondary structure that ordinarily sequester the 
ribosome binding site (RBS) and obstruct ribosome loading.  By preventing the formation 
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of such inhibitory structures in the mRNA target, sRNAs increase translation of target 
proteins (Fig. 1.1A) [37, 128].   
In contrast, repression of target mRNAs can be accomplished by inhibiting their 
translation and/or by altering their stability.  sRNAs can repress translation initiation of 
mRNA targets by binding to sites in the 5ʹ untranslated region (UTR) and occluding 
elements required for ribosome binding.  Most often, sRNA-mediated translation 
inhibition also leads to degradation of the sRNA-mRNA complex (Fig. 1.1D) [113].  In 
E. coli and Salmonella, RNase E and associated components of the degradosome [19] 
affect stability of the sRNA-mRNA complex [6, 18].    While most negative sRNA 
regulators cause both translational silencing and mRNA degradation, some sRNAs only 
affect one of these two processes.  For example, the sRNA Spot 42 regulates galK within 
the galETKM operon solely by inhibiting translation; the stability of the galK message is 
unaffected (Fig. 1.1B) [91].  On the other hand, the MicC sRNA does not inhibit 
translation of its target ompD.  Instead, it exclusively regulates gene expression at the 
level of ompD transcript stability by directly recruiting the degradosome complex to the 
binding site and promoting ompD mRNA degradation (Fig. 1.1C) [107].  
 Physiological roles of small RNAs: The mechanisms by which sRNAs regulate 
gene expression are diverse.  Equally diverse are the impacts they have on the physiology 
of bacterial cells.  Similar to other cellular responses, sRNAs are induced by and respond 
to specific environmental signals.  With the use of various whole genome approaches to 
identify sRNAs, their physiological roles in the cell are becoming more apparent.  They 
play a variety of cellular roles, including biofilm formation, virulence, quorum sensing, 
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carbon metabolism and iron starvation to name a few [118].  Examples of two well-
characterized sRNAs that participate in cell physiology are outlined below.   
 The sRNA, RyhB, is involved in iron homeostasis:  Acquisition and homeostasis 
of iron in bacteria is a tightly regulated process because iron is both essential in small 
quantities and toxic in large quantities to bacterial cells [97].  Pathogenic bacteria are 
further challenged in acquiring iron since iron is present only at limiting concentrations in 
eukaryotic host cells [97].  In E. coli, the ferric uptake regulator (Fur) maintains iron 
homeostasis by regulating expression of several genes in response to intracellular iron 
concentrations.  The sRNA RyhB is one such gene that is regulated by Fur [81, 83].  
Under iron-rich conditions, RyhB expression is repressed by iron-bound Fur.  During this 
state, Fur also represses expression of genes that are involved in iron acquisition.  In 
contrast, when cells are starved for iron, RyhB expression is induced due to de-repression 
by Fur (that is no longer bound to iron).  Consequently, RyhB negatively regulates non-
essential genes that require iron as co-factors.  These targets include iron storage proteins, 
some enzymes of the TCA cycle and the superoxide dismutase protein (SodB).  Such 
regulation by RyhB ensures that in iron-deplete conditions, the intracellular iron is 
diverted to essential pathways that require iron [83, 97].  Thus, by inducing expression of 
one sRNA, Fur regulates multiple genes, thereby maintaining constant levels of iron in 
the cell.   
 The sRNA, Spot 42, is involved in Carbon metabolism: Sugar uptake and carbon 
metabolism are also highly regulated processes in bacteria.  The CRP-cAMP global 
transcriptional complex plays a significant role in regulation of sugar uptake and 
metabolism.  Levels of CRP-cAMP are altered in response to glucose levels in the cell, 
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which in turn, regulates expression of several genes involved in sugar metabolism [26].  
The 109 nt sRNA, Spot 42, was found to be a member of the CRP-cAMP regulon [111].  
Spot 42 had been identified as early as the 1970s to be an abundantly expressed RNA 
under high glucose concentrations.  However, it wasn’t until the 1990s that Spot 42 
expression was shown to be dependent on CRP-cAMP [111].  Under high glucose 
concentrations, or low amounts of CRP-cAMP, Spot 42 levels are high.  Whereas, in 
glucose-limiting conditions, CRP-cAMP levels are high, and therefore Spot 42 
expression remains low.  The galETKM operon, encoding proteins involved in galactose 
catabolism and lipopolysaccharide synthesis, was found to be a target of Spot 42 [91] .  
However, not all of galETKM is regulated by Spot 42.  Spot 42 expression seemed to 
only negatively regulate GalK protein levels while synthesis of other proteins from this 
operon remained unaltered [91].  Moller, et.al proposed that this manner of discoordinate 
regulation serves a purpose. While cells are growing on galactose, all three enzymes 
(GalE, GalK and GalT) are essential for galactose metabolism.  Spot 42 remains 
repressed (and does not regulate galK) by the abundantly present CRP-cAMP when cells 
grow on galactose.  In contrast, when preferred carbon sources such as glucose are 
present, the galK gene product is dispensable for growth.  GalE and GalT are still 
required to produce certain precursors for lipopolysaccharide synthesis [91].  Thus, Spot 
42 serves to differentially regulate expression of galK in the galETKM operon, thereby 
curbing unwanted expression of genes in particular environmental conditions.   
1.2. The carbohydrate phosphoenolpyruvate phosphotransferase system 
Acquisition and utilization of various carbon sources is a highly essential and 
tightly regulated process in many bacteria.  One system that plays a major role in 
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transport of carbon sources and the regulation of this acquisition is the carbohydrate 
phosphoenolpyruvate phosphotransferase system (PTS) [112].  The carbohydrate PTS 
serves to both import sugars and simultaneously phosphorylate them as they enter the 
cell.  Phosphorylation of sugars occurs via a phosphorylation cascade mediated by a 
series of cytoplasmic and membrane proteins [112].  Lowest in the cascade is the 
glycolytic intermediate, phosphoenolpyruvate (PEP).  A phosphate molecule from PEP is 
donated to the cytoplasmic and sugar non-specific, EI (encoded by ptsI) protein of the 
PTS.  This is further transferred to another cytoplasmic, sugar non-specific protein called 
Hpr (encoded by ptsH).  Lastly, the phosphate is transmitted to the cytoplasmic, sugar-
specific, EIIA protein and the membrane-bound, sugar-specific, EIICB proteins [30, 
112].  This phosphorylation and translocation process results in conservation of energy 
during glycolysis.  Details of some sugar specific and non-specific PTS proteins relevant 
to this study are discussed below.  
1.2.1. The major glucose transporters EIIA
Glc
 and EIIBC
Glc
 
Metabolism of glucose is perhaps one of the most tightly regulated processes in E. 
coli cells. The EIIA
Glc
 and EIICB
Glc
 proteins of the glucose PTS specifically transport 
glucose into the cell [112].  The EIIA
Glc
 protein is the cytoplasmic, glucose-specific 
component of the PTS.  This protein, encoded by the crr (part of the ptsHIcrr) gene in E. 
coli and Salmonella, is 169 aa in length.  EIIA
Glc
  participates both in phosphate 
translocation through the PTS and has important regulatory functions in the cell [110].  
Site-directed mutagenesis studies and the crystal structure of this protein have aided in 
structure-function analysis of EIIA
Glc
 interactions with other proteins.  The amino 
terminus of IIA
Glc
 is important for the interaction and phosphorylation of IICB
Glc
,  
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whereas, the C-terminus containing a histidine residue at the active site of this protein 
(His-90) serves as a phosphate recipient from Hpr [114]. This active site also binds 
various proteins and allosterically inhibits their activity depending on the phosphorylation 
status of EIIA
Glc 
.  
The EIICB
Glc
 complex is the membrane-bound, glucose-specific transporter of the 
PTS.  This protein is encoded by ptsG and is 477 amino acids in length. The N-terminus, 
EIIC domain spans the membrane and is responsible for binding and transport of glucose.  
The C-terminus, EIIB domain, attached to EIIC via a flexible linker domain is 
responsible for phosphorylation of glucose [59].  
1.2.2. The broad sugar-substrate transporters EIIAB
Man
 and EIICD
Man
 
The EIIAB
Man
 and EIICD
Man 
proteins, originally named for their ability to 
transport mannose, were later shown to transport a variety of sugars into the cell.  In 
addition to transporting mannose, they can also bring in glucose, glucosamine and N-
acetylglucosamine [109].  Three polypeptides comprise the EIIAB
Man
 and EIICD
Man
 
transporters.  The manX gene encodes the cytoplasmic, EIIAB
Man
 component of this PTS.  
The two domains of this protein are fused together by a linker region [112].  The manY 
and manZ genes lying downstream of manX and that are in an operon with manX, encode 
EIIC and EIID respectively.  EIICD
Man
 are membrane bound, and although neither of the 
proteins are phosphorylated during import of sugars, both are required for 
phosphorylation of mannose during its transport [112].  
 In addition to the phosphorylation and the translocation functions, members of the 
PTS also play important regulatory roles in carbon metabolism.  Since PTS proteins 
transport sugars as well as regulate genes involved in sugar catabolism, they are crucial in 
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determining carbon flux in the cell.  Transcriptional and translational regulation of PTS 
sugar transporters were discovered as early as the 1970s [61, 112].  Given the importance 
of the glucose PTS in enteric bacteria, it is not surprising that they are also subject to 
post-transcriptional regulation.   
1.3. The small RNA SgrS-mediated regulation of sugar transporters 
 In the 1990s, a sRNA was found to regulate expression of a specific PTS protein 
in E. coli.  This sRNA, SgrS, was found to be expressed under a specific stress condition 
called sugar-phosphate stress.   
1.3.1. The sugar-phosphate stress  
Sugar-phosphate stress is caused by accumulation of phosphorylated sugars in 
bacterial cells.  This stress has long been known to be growth inhibitory to bacterial cells 
[150].  Induction of this stress was observed when bacterial cells were exposed to the 
non-metabolizable glucose analog, alpha-methyl glucoside (αMG) [150]. It is postulated 
that glucose analogs such as αMG are taken up by the cell but cannot be metabolized by 
downstream enzymes in glycolysis.  Therefore, the phosphorylated forms of these 
analogs accumulate in the cell, causing sugar-phosphate stress.   
Later studies demonstrated that the same stress could also be induced by mutating 
certain glycolytic enzymes [32, 68].  While the details of the growth inhibition caused by 
this stress is still unclear, recent studies have shown that the stress maybe the result of 
depletion of certain glycolytic intermediates, rather than simple accumulation of sugar-
phosphates [120].  
The first identification of glucose-phosphate stress linked to regulation of ptsG 
(stress caused by accumulation of glucose-6-phosphates in the cell) was by Kimata and 
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coworkers [68].  This group first discovered that mutating certain enzymes in glycolysis 
led to a marked reduction in ptsG mRNA levels [68].  Later, the same group showed that 
the same mutations induced accumulation of glucose-6-phosphate and fructose-6-
phosphate, which in turn led to destabilization of the ptsG mRNA [93].   Further, this 
decrease was dependent on the endoribonulease, RNase E, suggesting a post-
transcriptional mechanism of regulation [93].  These factors surrounding ptsG regulation 
led to the suspicion that a small RNA was involved in regulating ptsG.  
1.3.2. The small RNA SgrS 
 Discovery and link to sugar-phosphate stress: SgrS was a sRNA identified by 
Zhang, et.al during a co-immunoprecipitation study of the RNA chaperone Hfq [159].  
SgrS was one of several small RNAs in E. coli that co-immunoprecipitated along with 
Hfq.  Encoded at ~1.65 min on the E. coli chromosome, this sRNA was initially called 
RyaA [159].  To identify its physiological function in E. coli, RyaA was expressed from 
medium-copy plasmids and grown in minimal medium containing PTS sugars. 
Overexpression of RyaA in certain PTS sugars (glucose and mannose) led to inhibition of 
cell growth, whereas RyaA did not inhibit growth in non-PTS and some other PTS sugars 
(such as trehalose and sorbitol) [139].  Thus, RyA was renamed SgrS, for sugar transport-
related sRNA.  Because both the glucose and mannose transporters (ptsG and manXYZ, 
respectively) have the ability to transport glucose, SgrS was suspected to be involved in 
regulation of glucose metabolism.  Consistent with this idea, SgrS was induced during the 
addition of the glucose analog, αMG.  In addition, SgrS expression also led to 
degradation of ptsG mRNA [139].  Later studies by Aiba and group demonstrated that 
SgrS is also transcribed during accumulation of certain sugar-phosphates, such as when 
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mutating glycolytic enzyme [63].  Thus, SgrS was identified to be the missing link in the 
observations of post-transcriptional ptsG mRNA degradation by Morita et.al.[93].  
 Transcription of sgrS: The mapping of the 5′ and 3′ ends of sgrS [139] identified 
the SgrS transcript to be 227 nt in length in E. coli.  A rho-independent terminator 
marked by a strong secondary structure and a run of uracil resides were identified and 
postulated to cause transcription termination of SgrS [139].  Further, when the 
chromosomal position of the sgrS gene locus from E. coli, Salmonella and shigella 
species were analyzed, a gene lying directly upstream of sgrS, later called sgrR, was 
found to be present and highly conserved among several closely-related bacterial species.  
sgrR is divergently transcribed from sgrS and transcriptionally activates sgrS synthesis 
[140].  
 Role of SgrS in the sugar-phosphate stress response: An overview of the role of 
SgrS in sugar-phosphate stress response is shown in Fig. 1.2.  SgrS expression is induced 
under sugar-phosphate stress conditions.  Introduction of mutations in glycolytic enzymes 
such as pgi and pfkA is one way to cause sugar-phosphate stress [63, 69].  Another way to 
induce the stress is by treating cells with the non-metabolized glucose analogs αMG 
[139] and 2deoxyglucose (2DG) [69, 131].  Under such stress conditions, cells lacking a 
chromosomal copy of sgrS are severely growth inhibited [131, 139].  In contrast, cells 
with an intact sgrS exhibit a slight growth lag upon exposure to αMG, but quickly 
recover and grow similarly to untreated cells [139].  
As shown in Fig. 1.1, SgrS elicits a response to this stress by negatively 
regulating expression of sugar transporters that bring in the stress molecule (αMG or 
2DG, for instance) [115, 139].  In addition, SgrS positively regulates genes that are 
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essential for efflux of the toxic phosphosugars [103].  The specific genes it regulates and 
the importance of this regulation are discussed below.   
 SgrS targets and mechanisms of regulation: Various targets of sgrS have been 
characterized thus far.  One of the first characterized targets of SgrS is the ptsG mRNA, 
encoding the major glucose transporter EIICB
Glc
.  SgrS negatively regulates ptsG 
translation by binding to the RBS of the transcript and occluding ribosome binding [77, 
95]. Mutational analyses and gel-shift assays of SgrS and ptsG have demonstrated direct 
interaction of the two RNAs [77].  Further, SgrS-mediated destabilization of ptsG has 
been shown to be dependent on both Hfq and RNase E [94].  
Microarray analyses on SgrS overexpression in different media revealed another 
target of SgrS: manXYZ.  As described in section 1.2.2, the manXYZ operon encodes 
proteins involved in the transport of several sugars, including glucose.  Interactions 
between SgrS and manX was demonstrated by mutational analyses in SgrS and manX 
[115].  RNA footprinting experiments further showed binding of SgrS to manX.  In 
contrast to ptsG regulation, SgrS:manX pairing do not surround the manX RBS TIS.  
Instead, SgrS binds 60 nucleotides into the coding sequence (CDS) of manX and inhibits 
its translation.  In addition to silencing its translation, SgrS also leads to degradation of 
the manXYZ transcript with the aid of both Hfq and RNase E [115] 
Another characterized target of SgrS is the yigL mRNA.  Originally identified in 
microarray analyses, yigL mRNA was found to increase during SgrS overexpression 
[103].  yigL encodes a HAD-like sugar phosphatase enzyme in E. coli and Salmonella.  
Chromosomal yigL is required for SgrS-dependent rescue of cells from stress.  YigL 
presumably dephosphorylates α-MG-6-phosphate or accumulated phosphosugars.  This 
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dephosphorylation was shown to be critical for the efflux of αMG from the cell [103]; 
i.e., cells lacking yigL were inefficient in αMG export.   
1.3.3. SgrT 
As described in section 1.1.2, most trans-encoded sRNAs solely regulate gene 
expression by an RNA base pairing mechanism.  SgrS is unique in that in addition to its 
RNA function of regulating targets such as ptsG, manXYZ and yigL, it also produces a 
peptide called SgrT.  The production of this peptide was first discovered in 2007.  
Mutations in the predicted start codon of sgrT inactivated a translational sgrT-lacZ 
fusion, suggesting that SgrS indeed also has an mRNA function [146].  
 SgrT expressed ectopically from a heterologous promoter and RBS performed 
the same function as SgrS base pairing i.e., SgrT alone was sufficient to rescue cells from 
glucose-phosphate stress.  However, SgrT overexpression did not affect ptsG mRNA or 
protein levels unlike expression of SgrS, which affects both ptsG mRNA and PtsG 
protein levels.  These results together suggested that SgrT inhibits glucose uptake, but 
using a different mechanism than the base pairing function [146].  
Following this discovery, SgrT from closely-related enteric bacteria were studied 
[147].  Ectopic expression of SgrT from Salmonella enterica serovar Typhimurium, 
Yersinia pestis, Erwinia caratovora and Klebsiella pneumoniae were able to rescue E. 
coli cells lacking a chromosomal sgrST copy from glucose-phosphate stress.  The sgrS 
homologs also regulated expression of an E. coli translational ptsG′-′lacZ fusion.  In 
addition, the wild-type sgrS and homologs of sgrS base pairing mutants were tested for 
their ability to rescue stressed E. coli cells.  The mutants of sgrS tested were deficient in 
base pairing and regulating some critical targets, such that they were unable to provide 
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stress relief in E. coli.  Therefore, these mutants essentially only expressed SgrT.  
Surprisingly, an E. coli sgrS base pairing mutant could not rescue cells from stress, 
whereas the equivalent Salmonella sgrS mutant could, suggesting that when expressed 
from its native RBS, the E. coli SgrT was unable to contribute to the glucose-phosphate 
stress [147].  It was then discovered that SgrT is not abundantly produced from the native 
E. coli sgrS due to a secondary structure surrounding the sgrT RBS that prevents SgrT 
translation [147].  The Salmonella sgrS however lacks the secondary structure and thus 
produces abundant SgrT [147].  
While many sRNA regulators have been identified in several bacteria and 
archaeal species, not many sRNAs are dual-function regulators.  SgrS is the only known 
example of a sRNA that performs two functions participating in the same stress response.  
Many aspects of bifunctional regulators are poorly understood.  
1.4. The small RNA DicF 
 SgrS is one example of a well-characterized sRNA that alters expression of some 
PTS proteins.  A screen was performed in our laboratory to detect any post-
transcriptional regulation of another gene in the PTS called ptsH. A sRNA called DicF 
was isolated from the screen, and it seemed to have moderate effect on ptsH expression 
(Balasubramanian and Vanderpool, unpublished).  In an effort to understand if DicF 
indeed does regulate sugar transport and metabolism, this study also focuses on 
characterizing the targets of the sRNA DicF.   
1.4.1. Discovery  
The DicF sRNA was discovered fortuitously in the late 1980s.  It was identified in 
a transposon screen seeking mutations in E. coli that affect cell division.  Initially, one 
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ORF of the Qin prophage, DicB, was isolated from the screen and was found to be a cell 
division inhibitor [7, 8].  Overexpression of a plasmid that contained DicB and DNA 
sequences surrounding DicB led to filamentation of cells.  Surprisingly, truncations of 
this clone revealed that the region upstream of the DicB ORF also led to growth 
inhibition [13].  Although no ORF was detected in this upstream sequence, a region of 
about 90 nucleotides was found to inhibit cell division.  Further analysis revealed that 
transcription, but not translation of this clone caused the cell inhibition phenotype, 
suggesting that perhaps an RNA molecule was the responsible regulator [13].  This RNA 
molecule was called DicF.   
 Transcription:  DicB and DicF were found to be transcribed as part of a ~800nt 
operon on the Qin prophage (termed as dicBF).  The genomic locus of dicF is shown in 
Fig. 1.3.  The dicBF operon contains a total of five ORFS and a single promoter before 
the start of ORF1 encoding ydfA.  The first three ORFs (ydfA, ydfB and ydfC) encode 
proteins of unknown functions.  The dicB gene sequence is located about 520 nt 
downstream of ydfC [35].  The DicF RNA is transcribed from the long untranslated 
region between ydfC and dicB.  The DicBF operon undergoes extensive processing by 
two ribonuclease complexes: RNase E and RNase III.  The biologically active DicF RNA 
is produced from the operon by processing mediated by RNase E and RNase III.  Further, 
an intrinsic hairpin structure towards the 3′ end of dicF and a Rho-independent terminator 
sequence leads to the production of the 53nt-DicF RNA [34].  The only confirmed 
promoter of the dicBF operon is located upstream of ydfA.  Genes downstream of DicF 
are postulated to be transcribed from read-through transcription of dicF and from the 
dicBF promoter.   
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   The Qin prophage is one of nine defective prophages in E. coli.  It is a lambdoid 
prophage with a defective integrase and is therefore a part of the E. coli chromosome.  
Since this sRNA is encoded on a cryptic prophage, the conditions that activate 
transcription of DicF are not yet known.  However, expression of the dicBF operon is 
regulated by two proteins: a cro-like repressor DicC and a bacteriophage P22 C2-like 
repressor DicA [7, 9].  In fact, DicB and DicF were first identified as cell division 
inhibitors by studying suppressors of DicA [9].  
 Targets of DicF and roles in cell physiology: Although DicF has been implicated 
in inhibition of cell division, not much is known about its targets.  One target of DicF 
discovered by the Bouche group is the ftsZ mRNA [133].  This group discovered that 
while both a ftsZ′-′lacZ translational fusion and FtsZ protein levels decreased during DicF 
overexpression, a ftsZ-lacZ transcriptional fusion was only slightly affected by DicF.  
This result suggested that DicF might act on ftsZ by an antisense base pairing mechanism 
[133].  Consistent with this result, overexpression of DicF from an ectopic promoter leads 
to filamentation of cells and leads to growth inhibition of cells [133].  Apart from ftsZ, no 
other targets of DicF have been identified.   
1.4.2. Distribution of DicF in bacteria 
 A study undertaken by Faulbadier and Bouche to identify the distribution of dicF 
sequences in E. coli and other bacterial species had surprising revelations.  First, dicF 
was found in several E. coli species that carried remnants of the Qin prophage [35].  
Second, two species of Shigella also seemed to possess dicF-like sequences.  Third, 
another defective prophage in E. coli, the Rac prophage, has somewhat similar sequences 
to dicF and its surrounding sequences [35].  A Southern blot with a probe specific to dicF 
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and its surrounding RNA regions revealed two bands: a strong band corresponding to the 
Qin prophage and a weaker band corresponding to sequences in the Rac prophage [35].  
Alignment of the dicF-like sequences from both the Qin and the Rac prophages divulged 
that the regions surrounding dicF that are processed by RNase E and RNase III are very 
highly conserved, although the sRNA itself is not conserved [35].  
1.5. Aim of this study 
 In the past decade, bacterial trans-acting sRNAs have been established as 
important post-transcriptional regulators of gene expression.  They have been shown to 
play a multitude of physiological roles in both bacteria and eukaryotes.  Two sRNAs are 
the subject of this study.   
 1. The sRNA SgrS.  SgrS is a sRNA that is activated under glucose-phosphate 
stress.  This bifunctional sRNA, unlike most other sRNAs, has both a base pairing RNA 
function and an mRNA function (producing SgrT).  The base pairing function of SgrS 
regulates a number of mRNA targets, resulting in reduced uptake and enhanced efflux of 
sugars.  SgrS also encodes the SgrT protein, which reduces sugar uptake by a mechanism 
that is independent of base pairing.  While SgrS base pairing activity has been 
characterized in detail, little is known about how base pairing and translation of sgrT are 
coordinated.  The first part of this study intends to decipher the relationship between the 
two functions of SgrS.  Investigating interactions between the dual functions of SgrS will 
shed light on mechanistic and physiological aspects of the rare, bifunctional RNA 
regulators.  Chapter 3 of this study delves in the dual-aspects of SgrS.   
 Work of a previous graduate student, Dr. Jennifer Rice, in our laboratory 
identified the manXYZ message as a target of SgrS [115].  This study also contributes to 
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Dr. Rice’s discovery by characterizing the mechanism by which SgrS regulates the 
manXYZ operon.  Investigating the SgrS regulation of the manXYZ operon could provide 
insights into mechanisms by which sRNAs regulate polycistronic transcripts.  Chapter 5 
of this study analyzes SgrS regulation of the manXYZ polycistron.   
 2. The sRNA DicF.  DicF is a sRNA that is encoded on the defective Qin 
prophage in E. coli.  Although this sRNA was one of the first identified regulatory RNAs 
in bacteria, the only known target of DicF is the ftsZ mRNA.  The second part of this 
study aims to identify the DicF regulon.  Unpublished data from our group suggested that 
DicF might regulate targets in sugar uptake and in central metabolism.  Identifying the 
DicF regulon would better enable our understanding of this sRNA, giving insights into its 
possible function in the cell.  Chapter 4 investigates the different metabolic targets of 
DicF and the consequences of this regulation.   
 In chapter 2, the materials and methods used towards the research conducted in 
this study are described in detail.  Lastly, chapter 6 discusses the major conclusions of 
chapters 3, 4 and 5, and the future directions of the projects that this study has 
undertaken.   
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1.6. Figures 
 
Figure 1.1.  Base pairing interactions of trans-acting bacterial sRNAs and their 
regulatory outcomes.  Small RNAs (sRNAs) are indicated by blue arrows and 
messenger RNAs (mRNAs) by red arrows.  The ribosome binding sites (RBS) of the 
targets are denoted by the orange box.  Overlapping green circles indicate ribosomes.  
Dotted arrows denote ribosomes unable to load on the target mRNA.  sRNA-mRNA base 
pairing interactions are shown by a series of thin, black lines.  RNase E and the 
degradosome is represented by black, wedged circles.  sRNAs can A) positively regulate 
targets by base pairing to secondary structures and unmasking the RBS, allowing 
translation.  They can also regulate targets in a negative manner by B) inhibition of 
translation and stimulation of degradation C) only inhibiting translation or D) only 
stimulating degradation.   
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Figure 1.2. The role of SgrS in the glucose-phosphate stress response. Non-
metabolizable sugar-phosphates including αMG (blue hexagons) and 2DG (purple 
hexagons) are internalized through the PtsG and ManXYZ PTS transporters, 
respectively. αMG-6-phosphate and 2DG-6-phosphate accumulate intracellularly. 
This condition creates an unknown stress signal (orange sun) that is recognized by 
the transcription factor SgrR, which then activates transcription of sgrST. SgrS binds 
Hfq and base pairs with ptsG and manXYZ mRNAs to negatively regulate their 
translation and promote their degradation via RNase E. Production of SgrT inhibits 
glucose transport via a separate pathway.  
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Figure 1.3.  The dicBF gene locus.  The dicBF gene locus consists of five ORFS: ydfA, 
ydfB, rzpQ, dicB and ydfD.  The DicF RNA is transcribed from the yzpQ-dicB intergenic 
region.  After transcription, the biological active DicF RNA is made by processing 
mediated by RNase E and RNase III indicated by the arrows.   
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Chapter 2: Materials and methods 
2.1. Strains and plasmid construction 
All strains and plasmids used in this study are summarized in Table 2.1 and the 
oligonucleotides (obtained from IDT) listed in Table 2.2.  
Plasmids used in chapter 3 are derived from three different parental plasmids.  
The “pBRCS” plasmids [147] are derived from the medium-copy plasmid pBR322 
(maintained at 15-20 copies/cell), which has the pMB1 replicon.  The expression of sgrS 
alleles cloned on pBRCS plasmids is driven by the PLlac-O1 promoter [74].  The “pZA” 
plasmids [72] are derived from medium-copy pZA31luc [74], which contains the p15A 
replicon.  The expression of sgrS alleles cloned on pZA plasmids is driven by the PLtet-O1 
promoter [74].  The “pZE” plasmids [72] are derived from the pZE12luc plasmid [74] 
and are maintained at 50-70 copies/cell. The expression of known SgrS targets, ptsG, 
manXYZ and yigL cloned on pZE plasmids is driven by the PLlac-O1 promoter.   
The wild-type S. Typhimurium sgrS sequence was amplified using 
oligonucleotides O-DB151 and O-DB152 and cloned into the BamHI and NdeI cloning 
sites of the pZA31-R plasmid [72] to yield pZADB01.  The sgrS14 (pZADB05), sgrS19 
(pZADB12), sgrS21 (pZADB19), sgrS22 (pZADB20) and sgrS23 (pZADB21) alleles 
were created using QuikChange Mutagenesis (Agilent Technologies) on template 
pZADB01 using oligonucleotides listed in Table 2.2.  QuikChange Mutagenesis was also 
used on the sgrS19 (pZADB12) template to create the sgrS20 allele (pZADB18).   
For construction of translational reporter fusions, the super-folder gfp from the 
pXG-10 [137] was subcloned  to pZE12S [72] by Maksym Bobrovskyy in our laboratory 
to yield pZEMB8.  The S. Typhimurium ptsG (+1 transcription start site to 30 nts after 
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start codon) was amplified by PCR using oligonucleotides O-DB163 and O-DB164.  The 
E. coli manX region (+1 to 132 nts after the start codon) was amplified using 
oligonucleotides MBP2L and MBP2R44 and the E. coli yigL sequences were amplified 
using oligonucleotides MBP16F2 and MBPR41.  Plasmids pZEDB03 (ptsG′-′gfp), 
pZEMB11 (manX′-′gfp) and pZEMB15 (yigL′-′gfp) were constructed by cloning the 
appropriate PCR products into EcoR1 and KpnI sites on the plasmid pZEMB8.  Plasmids 
pZEMB11 and pZEMB15 were created by Maksym Bobrovskyy in our laboratory.  
The rne131 mutant (DB148) was constructed by P1 transduction of the λatt::lacIq, 
tetR cassette from EM1377 from the Masse laboratory [82].  This rne131 mutant was 
linked to kanamycin by Maksym Bobrovskyy in our laboratory to yield MB10.  This 
mutation was then moved into DB189, DB177 and DB228 to yield DB207, DB210 and 
DB239 respectively.  Similarly, the Δhfq::cat deletion mutant from EM1264 from the 
Masse laboratory was subject to P1 infection and was subsequently moved into DB189, 
DB177 and DB228 to yield DB206, DB209 and DB238.   
 The lacI
q 
gene encodes the super-repressor of the lac operon, so that multi-copy 
Plac promoters remain repressed until addition of the inducer IPTG.  Similarly, TetR 
represses multi-copy Ptet promoters, until the addition of the inducer anhydrotetracycline 
(aTc).  The Δhfq mutant (DB138) was created by P1 transduction of an hfq::cat allele 
from EM1264 [82] into a strain carrying λatt::lacIq, specR, tetR cassette (JH111,[115]).  
The Δhfq ptsG′-′lacZ fusion (DB151) was created by P1 transduction of the ptsG′-′lacZ 
fusion (linked to kanamycin) from JH258 (hfq
+
 ptsG′-′lacZ)  into DB138 [115].   
Mutations in the S. Typhimurium chromosome were made by first inserting a 
PBAD-kan
R
-ccdB cassette (generated using oligonucleotides O-DB173 and O-DB174) into 
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S. Typhimurium LT2, deleting nucleotides targeted for mutagenesis using lambda red 
recombination [31].  This resulted in strain DB139.  Second, PCR products generated 
using oligonucleotides O-DB109/110 (to make the sgrS1 mutation), O-DB106/107 (to 
make the sgrS2 mutant) and O-DB110/106 (to construct the sgrS3 mutant) containing the 
corresponding mutations were recombined independently into DB139.  Recombinants 
were subjected to counterselection on arabinose (for loss of the toxic ccdB gene product) 
and subsequently screened for arabinose-resistance and kanamycin sensitivity.  This led 
to the generation of strains with unmarked sgrS mutations: DB140 (sgrS1), DB142 
(sgrS2) and DB143 (sgrS3).  The sgrS::tet (DB111) strain was created using lambda red 
recombination as described previously [31] using a PCR product generated using 
oligonucleotides O-DB104 and O-DB105.  
The predicted targets of DicF were cloned into PM1205 as described in [79] and 
were used in chapter 4. Briefly, sequences of targets starting from the +1 site to 10 or 20 
amino acids of the gene was amplified with oligonucleotides containing homology to the 
PBAD and lacZ sequences.  Lambda red recombineering was used to generate the fusions 
described in chapter 4.  Sequences of the carB (O-DB429/430), rlmn (O-DB433/439), 
pgaA (O-DB427/428), ppK (O-DB425/426), mtrA (O-DB389/DB390), psiE (O-
DB391/392), clcA (O-DB393/394), glmS (O-DB441/442), cyoA (O-DB445/446), pykA 
(O-DB475/476), rbsD (PR108/109), rbsA (O-DB414-a/415), ptsP (O-DB447/448), glpK 
(O-DB418/419), xylR (O-DB385/386) and pfkA (O-DB360/362) genes were amplified 
using oligonucleotides shown in parentheses and were integrated into PM1205 [79].  
The qin::kan deletion was created by lambda red recombination using primers O-
DB413, 414.  This mutation was then moved into DB189 (xylR′-′lacZ), DB177 (pfkA′-
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′lacZ) and DB228 (pykA′-′lacZ) via P1 transduction.  The ftsZ′-′lacZ (DB188) fusion was 
created in PM1205 as described above using oligonucleotides O-DB403/377.  Different 
xylR′-′lacZ fusions were used in chapter 4.  xylR1′-′lacZ (DB202), containing the +1 site 
to the first amino acid of xylR, was created with oligonucleotides O-DB385 and O-
DB436.  The compensatory xylRcomp11′-′lacZ fusion (DB227) was constructed in PM1205 
with primers O-DB385 and O-DB458 (containing the xylR11 mutation).    
The Cp19-xylR strain (DB221) was made by amplifying the kanamycin linked 
constitutive, Cp19-promoter from JNB034 [115] using oligonucleotides O-DB463 and O-
DB464 and by lambda recombination of the linear PCR product onto the native xylR 
locus, thereby switching the promoter elements of xylR with Cp19 .  Following this, P1 
transduction was used to move Cp19-xylR into a strain with lacI
q
 to control expression of 
the Plac-plasmids, thus creating Cp19-xylR lacI
q
 (DB223).  The Cp19-pykA lacI
q
 (DB224) 
was created in a similar manner using oligonucleotides O-DB459 and O-DB460.   
The ΔxylR strain was obtained from the KEIO collection [4].  The DB176 strain 
was created by lambda red recombination of a dicF::kanamycin PCR product amplified 
using O-DB358/359.   
A Plac promoter sequence linked to chloramphenicol [131]was amplified using 
oligonucleotides O-DB479 and O-DB480 and recombined into a strain containing lacI
q
.  
This resulted in strain DB240.  Next, PCR products generated using oligonucleotides O-
DB508/509 (to make ΔdicB::kan deletion) and O-DB358/359 (to make the ΔdicF::kan 
deletion) were recombined independently into DB240 to create DB241 and DB242.  
Further, the kanamycin cassette in DB241 and DB242 were flipped using Pcp20 [31]and 
replaced with a frt-scar site [31].  Lastly, the dicF::kan PCR product was once again 
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recombined into DB243 to create the double ΔdicF ΔdicB mutant (DB245) in the context 
of the Plac-promoter.  The Plac-dicF mutant alleles used in chapter 4 were generated using 
the Quikchange mutagenesis II kit (stratagene).   
In chapter 5, several manX and manY mutant strains were created by first 
inserting a tet
R
 cassette using a PCR product generated by primers O-JH285/O-JH286; 
the resulting strain was JH339. To make the strain JH340 containing the manXGUG 
mutation under the control of the Cp19 promoter, a PCR product containing the mutation 
linked to a kan
R
-Cp19 cassette (amplified using O-JH104/O-JH287) was recombined into 
JH339 and colonies were screened for tet sensitivity.  The resulting kan
R
-Cp19-
manXGUGYZ cassette was transduced to create JH341 and JH342.  To create the strain 
JHDB01 containing the manXYS1Z construct, first, a PBAD-kan
R
-ccdB cassette (generated 
using oligonucleotides O-JH294 and O-JH295) was inserted into manY so that the manY 
nucleotides targeted for mutagenesis were deleted.  The resulting kanamycin-resistant 
and arabinose-sensitive strain was called JH349.  Second, a PCR product (obtained using 
oligonucleotides O-JH276 and O-JH289) containing the manYS1 mutation was 
recombined into JH349; strain JHDB01 was selected for arabinose-resistance and 
screened for kanamycin sensitivity.  The Kan
R
-Cp19 cassette (amplified using 
oligonucleotides O-JH104 and O-JH286) was then recombined into JHDB01 as described 
(12) to create JHDB02 (Kan
R
-Cp19-manXYS1Z). This cassette was then transduced into a 
wild-type background and verified by sequencing to create strain JHDB05. The Kan-
Cp19-manXGUGmanYS1Z was created starting with JHDB01.  A tet
R
 cassette (generated 
with oligonucleotides O-JHDB01 and O-JH287) was inserted in manX to delete the 
nucleotides targeted for mutagenesis. This strain is JHDB03. A PCR product containing 
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the CAC to GUG manX mutation linked to a kan
R
-CP19 promoter (obtained using O-
JH104 and O-JH287) was recombined into JHDB03 to replace the tetracycline cassette 
with Kan
R
-Cp19-manXGUG. The resulting JHDB04 strain contained kan
R
-Cp19-
manXGUGmanYS1Z.  A manXYZ deletion was created by Yan Sun in our laboratory by 
moving the ΔmanXYZ ::kan construct into DJ480.  
Plasmid pBRJH24, containing the A173T and C174G mutations in SgrS, was 
created using the QuikChange Mutagenesis Kit (Stratagene) with primers O-JH253 and 
the Plac-sgrS (pLCV1) plasmid as the template. 
 2.2. RNA extraction, Northern blot analysis and Quantitative Real-Time PCR 
 Strains carrying plasmids (containing vector or sgrS and its mutants) were grown 
overnight in LB with ampicillin.  They were then subcultured into fresh media with 
antibiotics and grown to mid-logarithmic phase.  When cultures reached an OD600 ~0.3, 
IPTG was added, and samples harvested at different time points.  To measure SgrS 
expression from the S. Typhimurium chromosome, 0.5% αMG was added to cultures at 
an OD600 ~0.4.  RNA was extracted by the hot phenol method as described in [1].  
 Northern blot analysis was carried out as described in [76]. Briefly, 3 g total 
RNA (for SgrS or DicF), 12 g total RNA (for ptsG mRNA) or 8g total RNA (for xylR, 
pykA or pfkA mRNAs) were run on acrylamide gels and 1% agarose gels using 1X TAE 
and 1X MOPS buffer, respectively.  RNA in acrylamide gels was transferred to a 0.2 m 
membrane (Whatmann) in 0.5X TAE buffer by electrophoresis.  RNA in agarose gels 
was transferred to by capillary transfer using 20X SSC.  Following transfer, the 
membranes were probed overnight with biotinylated DNA oligos (IDT) complementary 
to the specific RNA.  A probe specific to the ssrA RNA served as a loading control.  
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Detection was carried out according to the Brightstar Biodetect Kit (Ambion) 
instructions. ImageJ software was used to quantify the intensities of the mRNA levels.  
To perform quantitative real-time PCR, total RNA was extracted before (0 
minutes) and 30 minutes after αMG addition (28).  The total RNA was first reverse 
transcribed.  Reverse transcription was performed with 2µg DNase (Ambion)-treated 
RNA using Superscript III Reverse Transcriptase (Invitrogen). The manXYZ gene product 
was amplified from this resulting cDNA using Power SYBR-Green (Applied Biosystems) 
with oligonucleotides O-MBP18F1 and O-MBP18R1. The Cycle threshold (Ct) values of 
the manXYZ transcript were normalized to that of the housekeeping gene, rrsA, encoding 
the 16S rRNA. The amount of manXYZ at 0 minutes was used as the calibrator (and was 
normalized to 1.0) to calculate relative abundance of manXYZ mRNA post-αMG 
treatment. 
2.3. β-galactosidase assays  
 Strains were grown overnight in TB medium (with 100 g/ml ampicillin while 
carrying plasmids) and were subcultured into fresh medium with antibiotics and grown to 
mid-logarithmic phase.  When cultures reached an OD600 ~0.3, IPTG (isopropyl-β-D-
thiogalactopyranoside, Sigma Aldrich) was added at a final concentration of 1 mM to 
induce SgrS expression.  To measure translational repression of the different targets of 
DicF, 0.1mM IPTG was added to the cultures to induce expression of DicF.  Samples 
were harvested 20 minutes after IPTG induction (to measure regulation of ptsG by 
Salmonella SgrS) and 1 hour after IPTG induction (to measure regulation of dicF targets 
and manXYZ regulation by SgrS) and assayed for β-galactosidase activity as described 
previously [115]. 
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2.4. Kinetic fluorescence assays 
 Strains harboring two plasmids were grown overnight in defined MOPS rich 
medium (Teknova) with 0.2% fructose, 100 µg/ml ampicillin and 25 µg/ml 
chloramphenicol.  Cultures were subcultured 1:100 in fresh medium with antibiotics with 
the inducers IPTG and/or anhydro-tetracycline (aTc) from Sigma.  Triplicate samples of 
induced cultures were then grown with shaking in 48-well plates in a BMG OMEGA 
FLUOstar spectrophotometer at 37°C.  Measurements of OD600 and fluorescence were 
made every 20 minutes until cells reached an OD600 ~0.4.  RFU/OD600 was calculated at 
the same OD600 across 3 to 5 replicates [72].  
2.5. Protein extraction and Western blot analyses 
 Strains were grown overnight in LB or LB containing 100 g/ml ampicillin (if 
they carried plasmids).  They were subcultured in fresh media and grown to mid-log 
phase.  When assaying for SgrT levels in cells carrying plasmids, 1 mM IPTG was added 
to cultures at mid-log phase.  Samples were taken 20 minutes after IPTG addition and 
protein was harvested by TCA precipitation as described in [146].  For experiments 
monitoring SgrT production from chromosomal alleles, cultures were treated with 0.5% 
αMG at an OD600 ~0.1.  Total protein was harvested at various time points by TCA 
precipitation.  Samples were resuspended in SDS-PAGE loading buffer (Invitrogen) in 
volumes normalized to the OD600 of the culture.  Western blotting analyses were 
performed by running equal volumes of normalized protein samples on 4-12% Bis-Tris 
gels (Invitrogen) with 1X MES-SDS running buffer.  Proteins were then transferred to 
Immobilon-PSQ (Millipore) by electrophoresis using 1X transfer buffer.  SgrT was probed 
for using a 1:1000 dilution of -SgrT antiserum (raised in rabbits by Fisher) and a 1:5000 
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dilution of secondary -rabbit antiserum. The software ImageJ was used to quantify the 
intensities of SgrT normalized to the cross-reacting bands that served as internal loading 
controls.  
2.6. Growth assays 
 αMG rescue: E. coli strains harboring sgrS plasmids or Salmonella strains with 
chromosomal mutations were grown in minimal M63 glycerol medium overnight.  
Following a 1:200 subculture into fresh medium, cultures were grown until an OD600 of 
0.1 and 0.5% αMG was added.  Growth was monitored by measuring the optical density 
of the cultures at 600nm.  
 Glucose growth inhibition:  Strains carrying plasmids were grown in minimal 
M63 glycerol medium with ampicillin overnight.  Cells were then subcultured 1:200 into 
minimal glucose medium with ampicillin.  Growth was monitored over time by 
measuring the OD600 of cultures until they reached stationary phase.  
 LB growth inhibition:  Strains carrying plasmids of wild-type dicF, dicF mutants, 
or chromosomal constructs of Plac-dicBF were grown to an OD600 of ~0.1.  0.5mM IPTG 
was used to induce expression of DicF or the dicBF operon.  Growth was monitored over 
time by measuring the OD600 of cultures until they reached stationary phase.   
 Xylose growth inhibition:  A ΔdicF lacIq strain harboring the vector, dicF, dicF3 
and dicF9 plasmids were streaked on M63 xylose medium with and without 0.5mM 
IPTG.  Plates were imaged after 22 hours of incubation.   
 2DG phenotypes:  The strains containing wild-type or various manXYZ and sgrS 
chromosomal alleles were streaked on M63 fructose medium with and without 0.5% 
2DG. Plates were imaged after 20 hours of incubation. 
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2.7. RNA-Seq conditions and data analyses 
 Triplicates of a ΔdicF lacIq strain harboring the vector control plasmid or the 
plasmid containing dicF were grown to an OD600 of ~0.1 in LB with ampicillin.  0.5mM 
IPTG was added to the cultures to induce the vector or DicF.  RNA was harvested 5 
minutes and 20 minutes after induction, treated with DNase (Ambion) and checked for 
integrity on a 1% agarose gel. Library construction and sequencing was performed on the 
Illumina HiSeq2000 at the W.M. Keck Center for Comparative and Functional Genomics 
at the University of Illinois at Urbana Champaign.  Briefly, the ribosomal RNA was 
removed from 1ug total RNA submitted.  The libraries were then pooled in equimolar 
concentrations and quantified by quantitative PCR with the Library Quantification kit 
Illumina compatible (Kapa Biosystems).  The pooled libraries were sequences for 101 
cycles plus 7 cycles for the index read on a HiSeq2000 using TruSeq SBS version 3 
reagents.  The fastq files were generated with Casava 1.8.2 (Illumina).  The 
computational program Rockhopper [84] was used to analyze the RNA-Seq data.  
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2.8. Tables 
Table 2.1.  Strains and plasmids used in this study 
Strain  Description Source or Reference 
MG1655 Wild-type E. coli K-12 D. Jin (NCI) 
DJ480 MG1655 ΔlacX74 D. Jin (NCI) 
NM200 DJ480, miniλ::cm (carries λ red recombination functions) N. Majdalani, NCI 
NM2000 DJ480, mini λ::Cm, mal::lacIq N. Majdalani, NCI 
PM1205 DJ480 PBAD::cat-sacB::lacZ, mini λTet [79] 
LT2 Wild-type Salmonella enterica serovar Typhimurium LT2 Slauch, J.M (UIUC) 
CS100 DJ480 sgrS::cat-sacB [147] 
CS104 CS100 ΔsgrS [147] 
CS123 CS100 sgrS1 [147] 
CS175 JH111 ΔptsG::cat This study 
DB111 LT2 ΔsgrS::tet This study 
DB138 JH111 Δhfq::cat This study 
DB140 LT2 sgrS1 This study 
DB142 LT2 sgrS2 This study 
DB143 LT2 sgrS3 This study 
DB148 JH111 rne131 zce-726::Tn10 This study 
DB151 DB138 ptsG′-′lacZ This study 
DB153 LT2 sgrT-3XFLAG This study 
DB176 NM200 ΔdicF::kan This study 
DB177 PM1205 pfkA′-′lacZ This study 
DB189 PM1205 xylR′-′lacZ This study 
DB190 PM1205 ptsP′-′lacZ This study 
DB191 PM1205 mtrA′-′lacZ This study 
DB192 PM1205 psiE′-′lacZ This study 
DB193 PM1205 clcA′-′lacZ This study 
DB194 PM1205 glpK′-′lacZ This study 
DB195 PM1205 rbsA′-′lacZ This study 
DB196 PM1205 carB′-′lacZ This study 
DB197 PM1205 pgaA′-′lacZ This study 
DB198 PM1205 ppk′-′lacZ This study 
DB199 PM1205 rlmN′-′lacZ This study 
DB202 PM1205 xylR3trunc′-′lacZ This study 
DB206 DB189 Δhfq::cat This study 
DB207 DB189 rne131::kan This study 
DB209 DB177 Δhfq::cat This study 
DB210 DB177 rne131::kan This study 
DB214 PM1205 cyoA′-′lacZ This study 
DB215 PM1205 glmS′-′lacZ This study 
DB219 PM1205 rbsD′-′lacZ This study 
DB221 NM200 Cp19-xylR This study 
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 Table 2.1. (cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain  Description Source or Reference 
DB2227 PM1205 xylRcomp11′-′lacZ This study 
DB223 DB221 Cp19-xylR λattB::lacIq This study 
DB224 DB221 Cp19-pykA λattB::lacIq This study 
DB228 PM1205 pykA′-′lacZ This study 
DB238 DB228 Δhfq::cat This study 
DB239 DB228 rne131::kan This study 
DB240 NM2000 cat-Plac-dicBF This study 
DB241 DB240 ΔdicB::kan This study 
DB243 DB241 ΔdicB This study 
DB247 DB241 ΔdicF This study 
DB248 DB243 ΔdicB ΔdicF This study 
DB252 DB240 ΔdicF::kan This study 
JH111 CS104  λattB::lacIq- PN25tet
R
-spec
R
 [115] 
JH124 DJ480 Cp19-manXYZ, kan
R
 [115] 
JH125 CS104 Cp19-manXYZ, kan
R
 [115] 
JH193 Cp19-manX′-′lacZ [115] 
JH256 Cp19-manXY′-′lacZ [115] 
JH258 JH111 ptsG′-′lacZ [115] 
JH341 DJ480 manXGUGYZ, kan
R
 This study 
JHDB01 NM200 manXYS1Z This study 
JHDB05 DJ480 Cp19-manXYS1Z, kan
R
 This study 
JHDB07 DJ480-Cp19-manXGUGYS1Z, kan
R
 This study 
YS208 DJ480-ΔmanXYZ, kanR This study 
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Table 2.1. (cont.) 
 
Plasmids Genotype Primers Reference 
pHDB3 Vector control N/A [139] 
pLCV1 pHDB3 PLlacO-sgrS N/A [139] 
pBRJH24 pLCV1 PLlacO-sgrS24 O-JH253 This study 
pBRCS12 Vector N/A [147] 
pBRCS22 PLlacO-sgrS N/A [147] 
pBRCS27 PLlacO-sgrS1 N/A [147] 
pBRCS30 PLlacO-sgrS2 N/A [147] 
pBRCS31 PLlacO-sgrS3 N/A [147] 
pBRDB12 PLlacO-sgrS19 O-DB199 
O-DB200 
This study 
pLCV1 PLlacO-sgrS (E. coli) N/A [139] 
pZADB01 PLtet-sgrS O-DB151 
O-DB152 
This study 
pZADB05 PLtet-sgrS14 O-DB169 This study 
pZADB12 PLtet-sgrS19 O-DB188 
O-DB189 
This study 
pZADB18 PLtet-sgrS20 O-DB197 
O-DB198 
This study 
pZADB19 PLtet-sgrS21 O-DB199 
O-DB200 
This study 
pZADB20 PLtet-sgrS22 O-DB201 
O-DB202 
This study 
    
pZADB21 PLtet-sgrS23 O-DB203 
O-DB204 
This study 
pZEDB03 PLlacO-ptsG′-′gfp O-DB163 
O-DB164 
This study 
pZEMB11 PLlacO-manX′-′gfp MBP2L 
MBP2R44 
This study 
pZEMB15 PLlacO-yigL′-′gfp MBP16F2 
MBPR41 
This study 
Plac-vector Vector control N/A [80] 
Plac-dicF  N/A [80] 
Plac-dicF3  O-DB349 
O-DB350 
This study 
Plac-dicF8  O-DB397 
O-DB398 
This study 
Plac-dicF9  O-DB408 
O-DB409 
This study 
Plac-dicF11  O-DB451 
O-DB452 
This study 
Plac-dicF14  O-DB487 
O-DB488 
This study 
Plac-dicF15  O-DB489 
O-DB490 
This study 
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Table 2.1. (cont.) 
 
Plasmids Genotype Primers Reference 
Plac-dicF16  O-DB491 
O-DB492 
This study 
Plac-dicF21  O-DB501 
O-DB502 
This study 
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Table 2.2. Oligonucleotides used in this study 
Name Sequence 5'-3' 
O-DB104 CCAATAATATCTTTCGATGAAGCAAGAGGAAGAGGTCACTCTAGACATCATTAATTCCTAAT 
TTTTGTTGACAC 
O-DB105 TCTGCTGGCGGGTGATTTTAGGCTATCGCCTACACCAATAAGGTTTTATTTGAAGCTAAATC 
TTCTTTATCG 
O-DB106 CCAATAATATCTTTCGATGAAGCAAGAGGAAGAGGTCACTTAACGCCAGTTCTGGTTGAGAT 
O-DB107 TCTGCTGGCGGGTGATTTTAGGCGGGTGATTTTAGGCTATCGCCTACACC 
O-DB109 CCAATAATATCTTTCGATGAAGCAAGAGGAAGAGGTCACT 
O-DB110 TCTGCTGGCGGGTGATTTTAGGCTATCGCCTACACCAATAGTGAGTCACACATGATGTCTGC
AATTGG 
O-DB151 CCCCCATATGCGATGAAGCAAGCAAGAGGAAGAGG 
O-DB152 CCCCGGATCCCCAGAAACAGCCGAAATAAAAAAAGCC 
O-DB163 CCCGAATTCATAAATAAAAGGGCACTTAGA 
O-DB164 CCCGGTACCAGGCAGTTTGATACGGTAGAA 
O-DB169 GAGGTCACTATGCGCCAGTTCTGGTGAGATATTTTGCCGCGACGGAAAAAACGTCC 
O-DB173 CCAATAATATCTTTCGATGAAGCAAGAGGAAGAGGTCACTATAGGAACTTCAAGATCC 
O-DB174 TCTGCTGGCGGGTGATTTTAGGCTATCGCCTACACCAATATTATATTCCCCAGAACATCAG 
O-DB188 CGATGAAGCAAGAGGATCTCGTCACTTAACGCCAGTTCTGGTTGAG 
O-DB189 CTCAACCAGAACTGGCGTTAAGTGACGAGATCCTCTTGCTTCATCG 
O-DB197 GATGAAGCAAGTTTTTCTCGTCACTTAACGC 
O-DB198 GCGTTAAGTGACGAGAAAAACTTGCTTCATC 
O-DB199 CGATGAAGCAAGAGGAAGAGGATGCGCCAGTTCTGGGAG 
O-DB200 CTCCCAGAACTGGCGCATCCTCTTCCTCTTGCTTCATCG 
O-DB201 CGATGAAGCAAGAGGAAGAGGCTATGCGCCAGTTCTGGTTGAG 
O-DB202 CTCAACCAGAACTGGCGCATAGCCTCTTCCTCTTGCTTCATCG 
O-DB203 CAAGAGGAAGAGGTCACTGTGCGCCAGTTCTGGTTG 
O-DB204 CAACCAGAACTGGCGCACAGTGACCTCTTCCTCTTG 
O-DB230 CGCTTAAAAATGCTCGCGGAACTGATGCAGTGGGAGGCGAATAGGAACTTCAAGATCC 
O-DB231 CCTACACCAATACTCAGTCACACATGATGTCTGCAATTGGCTTCATTATATTCCCCAGAAC 
ATCAGG 
O-DB232 CGCTTAAAAATGCTCGCGGAACTGATGCAGTGGGAGGCGACCGAT 
O-DB233 CCTACACCAATACTCAGTCACACATGATGTCTGCAATTGGCTTCA 
O-DB349 CAAGATACTGACGTCTTTCTCCAGACGTTTGGCGGTATCA 
O-DB350 TGATACCGCCAAACGTCTGGAGAAAGACGTCAGTATCTTG 
O-DB358 TTTCTGGTGACGTTTGGCGGTATCAGTTTTACTCCGTGACGTGTAGGCTGGAGCTGCTTC 
O-DB359 GCGCTCAGCCGCATTCACCACATCACAAAATTCACTTTAAATTCCGGGGATCCGTCGACC 
O-DB360 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGATTTCATTTTGCATTCCAAAG 
O-DB362 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGCTTGTCAACACACCGATTTTC 
O-DB377 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGCCGCCGACGCCGATGACTT 
O-DB385 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGATAAAAATTTTCTCAAAGCC 
GGT 
O-DB386 TAACGCCAGGGTTTTCCCAGTGACGACGTTGTAAAACGACTAATGTGATGCGGTGACGTT 
O-DB389 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATACAGCCCCGATTTTTACCAT
CGG 
O-DB390 TAACGCCAGGGTTTTCCCAGTGACGACGTTGTAAAACGACAAGCAGCGACGGTGACGTTT 
O-DB391 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTCGCCACTGTGAAGGAGGTACT 
O-DB392 TAACGCCAGGGTTTTCCCAGTGACGACGTTGTAAAACGACCTCCACGCGCGGACGAGAGA 
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Table 2.2. (cont.) 
 
Name Sequence 5'-3' 
O-DB393 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATAACGTGCGAGTAAAATGCCG 
O-DB394 TAACGCCAGGGTTTTCCCAGTGACGACGTTGTAAAACGACCGGTGTTTCTAAAGAGGGAGTA 
O-DB397 GGTATCAGTTTTACTCCGTCTGTGCTCTGCCGCC 
O-DB398 CTTTAAAAAGGGCGGCAGAGCACAGACGGAGTAA 
O-DB403 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCCGTTTATACCGGTGGGGC 
O-DB408 GGTGACGTTTGGCGGTATCAGTTTTAGAGCGTGACT 
O-DB409 AAAAAGGGCGGCAGAGCAGTCACGCTCTAAAACTGATAC 
O-
DB414A 
ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCTGTGGGCAAGCTTAATCG 
O-DB415 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACCTGCTCCATCAGCCACGCTTT 
O-DB418 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCTTTACCGGCGGCAGAGACAT 
TCCTTAC 
O-DB419 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGACCGCGCGGGAGCTGGTGG 
O-DB425 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCTCGCCATAATATCCAGGC 
O-DB426 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGCGTTCATTGAACGATAACC 
O-DB427 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGAGAAAAGGATTTTATATGGAC
ACTCTGC 
O-DB428 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACAGTAAGAAGTTTCAAAGCCCAT
TTGG 
O-DB429 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCAGTACCGTAAAACCGCTA 
O-DB430 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGATAACAATCGGGCCCG 
O-DB433 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTACAATGCAGCGCCCCCGG 
O-DB434 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACCTCCCGCATCTGCTGACGGT 
O-DB436 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACTAATGTGATGCCCAGACGTTTA
GTAAACAT 
O-DB441 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTCACATGGGATGAGGAGATAA
CATAATCTCCC 
O-DB442 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACTTGCGCGATCGCGCCAACAA 
O-DB445 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACACTTTAAACGCCACCAGAT 
O-DB446 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACTAACAGCGCAGAATTACAGCC 
O-DB447 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGAAAGAGTTCGCGAGTGTGGTG
ATGTC 
O-DB448 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGAC 
CTCATTCAGGCGTGGTGCGC 
O-DB451 CAAGATACTGACGTCTTTCTGCTGACGTTTGGCGGTATCA 
O-DB452 TGATACCGCCAAACGTCAGCAGAAAGACGTCAGTATCTTG 
O-DB458 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACTAATGTGATGCGCTGACG 
TTTAGTAAACAT 
O-DB459 GATTTACTTTGCGACGCGGTGCAAAATTCAGAGATAACTTGTGTAGGCTGGAGCTGCTTCG 
O-DB460 TGGCGATAAATTAATCTCATTCGGATGTCGTATAAGATTATAACTATTATATCAACCCGGAT
CCCTCC 
O-DB463 GAGTATGATGGATGTACCGACCTTCTGGCAGTATATCGTTGTGTAGGCTGGAGCTGCTTCG 
O-DB464 ACCGGTAATACGTAACCGGCTTTGAGAAAATTTTTACAAATAACTATTATATCAACCCGGAT
CCCTCC 
O-DB475 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCTTATACGACATCCGAATGAGA
TTAATTTATCGC 
O-DB476 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACAAGCCTTCTGGACATGT 
AATACTCCG 
O-DB479 TCATCAATGAGTTATCTTTTACCACATCAATTATGTTAGCCCTGTGACGGAAGATCACTT 
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Table 2.2. (cont.) 
 
Name Sequence 5'-3' 
O-DB480 CACCGTGCGGTGTGTTGATGCAAACAAGATTAGCCATGACGTGCTCAGTATCTTGTTATC 
O-DB487 GGCGGTATCAGTTTTACTCGCTGACTGCTCTGCC 
O-DB488 GGGCGGCAGAGCAGTCAGCGAGTAAAACT  
O-DB489 GGCGGTATCAGTTTTACTCCGTCACTGCTCTGCC 
O-DB490 GGGCGGCAGAGCAGTGACGGAGTAAAACT 
O-DB491 CGGTATCAGTTTTACTCCGTGACTCGTCTGC 
O-DB492 GGGCGGCAGACGAGTCACGGAGTAAAACTGATA 
O-DB501 GTGACGTTTGGCGGTATCAGTTTATGTCCGTGACTG 
O-DB502 GGGCGGCAGAGCAGTCACGGACATAAACTGATACC 
O-DB503 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATAAGTGCGTATCGGCGCGCCG 
O-DB504 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGAC 
TGGTTCAAACATAGTTTCTCTCCGATTTGTGCCTGTC 
O-DB506 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGAC 
TGGTTCAAACATAGTTTCTCTCCGATTTCTGCCTGTC 
O-DB508 ATGAAAACGTTATTACCAAACGTTAATACGTCTGAAGGTTGTGTAGGCTGGAGCTGCTTC 
O-DB509 TCATTGTGCACATCCTTTTGGCATCAGACGTAAACGAGCCAATTCCGGGGATCCGTCGACC 
O-DB521 CTTAAGTGACAACCCCGCTGCAACGCCCTCTGTTATCAATGTGTAGGCTGGAGCTGCTTC 
O-DB522 GTGCGCTCAGCCGCATTCACCACATCACAAAATTCACTTTATTCCGGGGATCCGTCGACC 
O-JH104 TTACCTTTCGAAATTTCTGCTAATCGAAAGTTAAATTACGGTGTAGGCTGGAGCTGCTTCG 
O-JH276 GATCAGCAAAATCGATAAGTAACGTATTGTGTTGATTATCAGTGAGTTTTCACACTTAAGTC
TTACGTAAACAG 
O-JH283 AGACTTAAGTGTGTAAAGTGAGTGATAATCAACACAATACGTAACTATTATATCAACCCGGA
TCCCTCCTG 
O-JH286 GCCTAACAGCATTTCTGCCGTTTTAAGCAACTGCTCTGCAGAGGTTTTATTTGAAGCTAAAT
CTTCTTTATCG 
O-JH286 GCCTAACAGCATTTCTGCCGTTTTAAGCAACTGCTCTGCAGAGGTTTTATTTGAAGCTAAAT
CTTCTTTATCG 
O-JH287 GCCTAACAGCATTTCTGCCGTTTTAAGCAACTGCTCTGCAGCCCAACCATCACTGCCTATAA
CAATAGCAATGGTCACTTG 
O-
JHDB01 
TTACCTTTCGAAATTTCTGCTAATCGAAAGTTAAATTACGGATCTAGACATCATTAATTCC 
TAATTTTTGTTGACACTC  
O-
MBP18F 
CTCGACACCACTAAAGGCGTGCTG 
O-
MBP18R 
CGTTTCCACGAGCATTGGAATGTTAACG  
O-PR108 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATAGCGAAACGTTTCGCTGATGGA 
O-PR109 TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTCCCAGACGGGAGATCACC 
O-YS193 AGGCCTTCGGGTTGTAAAGT 
O-YS194 ATTCCGATTAACGCTTGCAC 
dicF  /5BIO/AGATACTGACGTCTTTCTGGTCTGGTTTGGCGGTATCAGTTT  
pfkA  /5BIO/GTCATAAATACCCATTACTTCCAG 
pykA  /5BIO/GCGATCTGTTGCTGGGCCTAACGTGGTAACGATTTTTGTT 
sgrS  /5BIO/ GCCAGCCAGGACGTTTTTTCCGTCGCGGC 
ssrA  /5BIO/CGCCACTAACAAACTAGCCTGA 
xylR  /5BIO/GGTAACTTTCTGCAAGGTGATACG 
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Chapter 3: Deciphering the interplay between two independent functions of the 
small RNA regulator SgrS in Salmonella  
3.1. Introduction 
 SgrS is a bifunctional sRNA that has both a base pairing RNA function and an 
mRNA function producing the peptide SgrT.  The riboregulation function allows 
decreased uptake of sugars via repression of transporters.  It also increases sugar efflux 
by promoting sugar phosphatase synthesis, which is a prerequisite for efflux [103]. SgrT 
also prevents uptake of sugar-phosphates, but by a different mechanism that acts at the 
level of sugar transporter (PtsG) activity [146].  Of the bifunctional sRNAs, SgrS is the 
only one known thus far whose RNA and protein functions contribute to the same stress 
response [138].  While SgrS-target mRNA base pairing interactions and SgrT function 
have been individually characterized [64, 146], little is known about how these two 
functions interact with or influence one another.  
In a previous study, we tested the ability of SgrS orthologs from other enteric 
bacteria to rescue E. coli cell growth during glucose-phosphate stress [147].  A striking 
result of that study was that significantly more SgrT was produced from the Salmonella 
enterica serovar Typhimurium (S. Typhimurium) versus the E. coli SgrS orthologs due to 
a hairpin structure present in the E. coli SgrS (and absent in S. Typhimurium) that inhibits 
sgrT translation [147].  Given the increased production of SgrT from the S. Typhimurium 
SgrS, and the demonstrated functionality of both base pairing [102, 103, 147] and SgrT 
[147] for this ortholog, we sought to investigate how these two functions are coordinated 
on the S. Typhimurium SgrS molecule.  
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A dual-function sRNA like SgrS must associate with different sets of protein and 
RNA cofactors to carry out each of its two activities.  For riboregulation, SgrS associates 
with its target mRNA as well as the RNA chaperone Hfq and components of the RNase E 
degradosome complex [94].  In order to be translated, SgrS must bind ribosomes.  It 
seems likely that a given molecule of SgrS can only associate with one of these large 
RNA-protein complexes at a time.  Thus, SgrS riboregulation and sgrT translation might 
compete with one another in the sense that if an SgrS molecule is ribosome-associated for 
the purpose of sgrT translation, it is unavailable for riboregulation and vice versa.  In this 
study, we utilize SgrS as a model dual-function sRNA to investigate how base pairing 
and translation activities affect one another.  We utilize sgrS mutants impaired for either 
base pairing or translation initiation at sgrT to gain insight into whether the two functions 
can act in tandem (i.e., a single SgrS molecule simultaneously being translated and acting 
as a riboregulator) or instead are mutually exclusive.  If riboregulation and translation can 
take place simultaneously, we postulated that mutations that impair one function might 
have little effect on the other.  On the other hand, if the two functions are mutually-
exclusive, we hypothesized that mutation of one might enhance the other by increasing 
the total SgrS pool available to perform the other activity.  In this chapter, we present 
evidence suggesting that the SgrS base pairing function and SgrT production are mutually 
exclusive.  Further, we demonstrate that the SgrS RNA is produced rapidly in response to 
initial stress in S. Typhimurium and that the base pairing activity is critical for recovery 
of cells from αMG stress.  In contrast, the SgrT protein is only produced later after the 
onset of stress and seems to act as an accessory in the S. Typhimurium response to 
glucose-phosphate stress.   
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3.2. Results 
3.2.1. Ectopic expression of SgrS base pairing and SgrT in Salmonella 
The S. Typhimurium sgrS sequence is shown in Fig. 3.1.  It is 43% identical to the 
E. coli sgrS sequence.  Since S. Typhimurium SgrS produces SgrT in greater abundance 
compared with E. coli SgrS [147] and has a base pairing activity that participates in the 
glucose-phosphate stress response [103], we studied the interplay between translation and 
riboregulation using S. Typhimurium sgrS alleles.  We began this investigation by testing 
the individual contributions of the two functions to the glucose-phosphate stress response 
in S. Typhimurium.  Plasmid constructs containing the S. Typhimurium wild-type sgrS or 
sgrS mutants were transformed into a ΔsgrS S. Typhimurium host and assayed for 
growth.  The mutants lacked either the base pairing function or the ability to produce 
SgrT (Fig. 3.2A).  The sgrS1 allele contains mutations that disrupt the ability of SgrS1 to 
base pair with several targets, including ptsG and yigL [64, 103, 147]; regulation of these 
targets is known to be important for the response to stress in E. coli and Salmonella [109, 
131]. The sgrS2 allele has a mutation in the sgrT start codon, but retains a functional base 
pairing region.  Lastly, mutations in the negative control sgrS3 combine both the start 
codon and base pairing mutations (Fig. 3.2A).  Growth of S. Typhimurium strains 
constitutively expressing these mutant alleles was monitored before and after stress 
induction by addition of αMG.  As expected, ectopic expression of wild-type SgrS 
rescued cells from growth inhibition during αMG stress (Fig. 3.2B), whereas ΔsgrS cells 
with the empty vector or sgrS3 were severely growth inhibited during stress.  Mutants 
that lacked either function individually (sgrS1 and sgrS2) grew similarly to the wild-type 
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strain, suggesting that either SgrS function is capable of providing stress relief when 
overexpressed.  
Another SgrS-associated phenotype is growth inhibition of cells overexpressing 
SgrS on minimal glucose media [139].  To characterize the individual roles of the base 
pairing function and SgrT in this phenotype, sgrS, sgrS1, sgrS2 and sgrS3 alleles were 
constitutively expressed in an S. Typhimurium ΔsgrS strain grown in glucose minimal 
liquid medium.  As shown in Fig. 3.2B, cells overexpressing either sgrS1 or sgrS2 
showed growth inhibition comparable to cells expressing wild-type SgrS.  In contrast, 
cells harboring the negative controls sgrS3 or vector did not exhibit growth inhibition 
under these conditions.  These data implied that either base pairing or SgrT activity is 
sufficient to prevent glucose uptake.  Consistent with our previous work in E. coli [146], 
the data suggest that SgrT and the base pairing function can act independently and that 
either can rescue cell growth during stress. 
3.2.2. Translation of sgrT has minimal effects on SgrS riboregulation 
To further examine whether translation affects the efficiency of riboregulation, we 
tested the effects of several different mutations in the sgrT translation initiation region on 
the efficiency of base pairing-dependent translational regulation.  A ptsG′-′gfp 
translational fusion was used to monitor SgrS-dependent translational repression.  
Mutations in the sgrT translation initiation region (Fig. 3.3A) include some expected to 
severely impair sgrT translation (sgrS19 and sgrS20), some expected to moderately 
reduce sgrT translation (sgrS21 and sgrS22), and one that should yield a minor reduction 
in translation (sgrS23).  Steady-state SgrS levels from these translation-deficient sgrS 
alleles were similar when measured by Northern blots (Fig. 3.10).  Consistent with 
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previous studies [147], wild-type SgrS caused a 5-fold repression of ptsG′-′gfp activity 
(Fig. 3.3B).  All mutant alleles expressing SgrS with minor (sgrS23), moderate 
(sgrS21/sgrS22) or severe (sgrS19/sgrS20) defects in sgrT translation still repressed ptsG 
translation to a degree similar to wild-type SgrS (Fig. 3.3B).  We also examined how 
these mutants regulated two other SgrS targets: manXYZ and yigL.  As shown in Fig. 
3.11, sgrS mutant alleles regulated expression of both manXYZ and yigL similarly to 
wild-type SgrS. These results are consistent with observations by other groups, where 
mutations in sgrT translation sequences have neutral effects on regulation of SgrS targets 
in S. Typhimurium: yigL and sopD (that encodes a secreted virulence factor in S. 
Typhimurium) [101, 103].  In sum, these data indicate that mutations that impair sgrT 
translation or that change the distance between sgrT and the base pairing region have no 
major effect on the ability of SgrS to regulate mRNA targets via base pairing.  
3.2.3. Mutations in the sgrS base pairing lead to increased SgrT production 
To determine how the base pairing function affects SgrT protein production, we 
monitored SgrS RNA and SgrT protein levels in cells expressing wild-type sgrS and 
sgrS1 (defective for base pairing, Fig. 3.2A) using Northern and Western blots, 
respectively.  Northern blots demonstrated that SgrS and SgrS1 RNA accumulated to 
similar levels by 20 minutes after induction of the plasmid-borne sgrS alleles (Fig. 3.4A).  
On the contrary, Western blots (using an α-SgrT antibody) revealed that ~2-fold more 
SgrT was produced from the base pairing-deficient SgrS1 compared to wild-type SgrS 
(Fig. 3.4B).  Since so little SgrT is produced by the wild-type SgrS allele, accurate 
quantitation was difficult, and the 2-fold difference is likely an under-estimate.  These 
data imply that while mutation of sgrT translation signals does not significantly impact 
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SgrS base pairing properties, mutation of base pairing residues results in enhanced SgrT 
production.  
Next, we examined the role of the RNase E degradosome complex (involved in 
SgrS-dependent target mRNA destabilization) on SgrS riboregulation and translation 
functions.  SgrS-mediated degradation of target mRNAs such as ptsG and manXYZ 
requires the RNase E degradosome [94].  The rne131 allele encodes a truncated RNase E 
that is defective for degradosome assembly [73].   It was shown previously that SgrS still 
represses translation of targets in an rne131 mutant, even though mRNA degradation is 
defective in this background [77, 96, 115].  In other words, in the absence of 
degradosome assembly, coupled degradation of SgrS-mRNA complexes is abolished 
while base pairing and translational silencing proceeds.  We hypothesized that increased 
stability of SgrS in an rne131 background compared with a wild-type rne
+
 host might 
allow increased SgrT production in the former strain background.  To test this hypothesis, 
wild-type SgrS and SgrS1 were ectopically produced in rne
+
 and rne131 strains, and 
SgrS RNA and SgrT levels were measured.  As shown in Fig. 3.5A, similarly high levels 
of SgrS RNA were detected from wild-type SgrS and SgrS1 in both strains (likely 
because alleles are being overexpressed from a heterologous promoter).  Western blot 
analyses again revealed ~2-fold greater SgrT production from SgrS1 compared to wild-
type SgrS in the rne
+
 background (Fig. 3.5B).  In the rne131 mutant, SgrT was still 
produced in ~2-fold greater abundance in sgrS1-expressing cells compared to sgrS-
expressing cells (Fig. 3.5B).  Disrupting the base pairing function of SgrS in the rne131 
background still increased SgrT production, suggesting that even in a situation where 
SgrS is not co-degraded with mRNA targets, the riboregulation function limits SgrT 
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synthesis.  This observation is consistent with the idea that SgrS molecules engaged in 
riboregulation are unavailable for translation and thus impairing base pairing activity 
increases the pool of SgrS molecules available to ribosomes for translation of sgrT.  We 
noted that in the rne131 mutant, there were reduced levels of SgrT overall (Fig. 3.5B), 
even though SgrS RNA levels appeared similar to those in the rne
+
 strain (Fig. 3.5A).  In 
a previous study, we observed decreased translation of reporter gene fusions in the 
rne131 background [116].  We hypothesize that reduced protein production in these cases 
may be due to pleiotropic effects of the degradosome mutation.  RNase E plays a key role 
in ribosome biogenesis due to its role in processing ribosomal RNAs.  Moreover, RNase 
E has been implicated in general ribosome function [134, 136] and specifically in 
regulation of mRNA targets by sRNAs (reviewed in [28]).  While the precise mechanism 
underlying reduced SgrT production in the rne131 background is unclear, the consistent 
difference between wild-type and base pairing deficient SgrS implies that active 
riboregulation makes less SgrS available for SgrT synthesis.   
3.2.4. SgrT production increases when base pairing activity is impaired without Hfq 
Aiba and coworkers showed that the SgrS-ptsG mRNA duplex exists as a 
complex with Hfq and the degradosome [94].  Thus, in the rne131 mutant, while the 
degradosome is not formed, SgrS will still be in complex with Hfq and targets such as 
ptsG mRNA, likely rendering it unavailable to ribosomes.  Therefore, we postulated that 
impairing the ability of SgrS to base pair with targets by mutation of hfq might further 
increase the number of SgrS molecules available for SgrT translation.  Consistent with 
this hypothesis, when SgrT levels were measured in cells expressing wild-type SgrS or 
SgrS1 in a Δhfq background, equal amounts of SgrT were observed in both strains (Fig. 
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3.6A).  This contrasts with the higher levels of SgrT production from SgrS1 compared to 
wild-type SgrS in the hfq
+
 background (Fig. 3.6A).  This result is consistent with the idea 
that when SgrS is prevented from base pairing with mRNA targets, more SgrS molecules 
are available for translation into SgrT. 
Previous studies demonstrated that the E. coli SgrS is present at much lower 
levels in an hfq mutant, presumably due to reduced stability [2, 100].  However, the fact 
that SgrT was still produced from S. Typhimurium SgrS and SgrS1 in an hfq mutant host 
suggested that S. Typhimurium SgrS molecules might be more stable than E. coli SgrS in 
this background.  To examine this, we measured levels of E. coli and S. Typhimurium 
SgrS (and mutant variants) produced from inducible plasmids in wild-type and hfq 
mutant strains.  Strains expressing S. Typhimurium wild-type sgrS, sgrS19 (translation-
deficient S. Typhimurium sgrS, Fig. 3.3A) and E. coli wild-type sgrS (naturally 
translation-deficient owing to the 5'-end secondary structure [147] were assessed for SgrS 
levels by Northern blot.  Steady state levels of S. Typhimurium wild-type SgrS were 
similar in hfq+ and hfq strains (Fig. 3.6B, compare lanes 2 versus 6, “S. Ty SgrS”), 
whereas SgrS19 levels were reduced by ~3.5-fold in the hfq compared to the wild-type 
strain (Fig. 3.6B, compare lanes 3 versus 7, “S. Ty SgrS19”).  As seen previously [2], E. 
coli SgrS is significantly less abundant (~7-fold) in the Δhfq compared to the hfq+ 
background (Fig. 3.6B, compare lanes 4 versus 8, “E. coli SgrS”).   These results suggest 
that translation of Salmonella sgrT contributes partially to the stability of SgrS, and that 
there are likely other determinants (perhaps differences in structure) that make 
Salmonella SgrS more stable than E. coli SgrS in the hfq mutant background. 
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Since the S. Typhimurium SgrS was expressed stably in the Δhfq background, we 
tested whether it could still regulate ptsG mRNA at the level of target mRNA stability or 
translation.  SgrS-mediated changes in ptsG mRNA levels and translational regulation of 
ptsG'-'lacZ in hfq
+
 and Δhfq hosts were monitored by Northern blot and -galactosidase 
assays, respectively (Fig. 3.6B, 3.6C).  Salmonella SgrS and SgrS19 (translation-
deficient) both efficiently reduced ptsG mRNA levels (Fig. 3.6B, lanes 2 and 3) and 
repressed ptsG translation (Fig. 3.6C) in the hfq+ background.  In contrast, in the Δhfq 
background, S. Typhimurium SgrS failed to significantly reduce ptsG mRNA levels (Fig. 
3.6B, lane 6) and was impaired in its ability to repress ptsG translation (Fig. 3.6C).  The 
S. Typhimurium translation-deficient SgrS19 also failed to reduce ptsG mRNA levels 
(Fig. 3.6B, lane 7) and was even more impaired for translational regulation (Fig. 3.6C).  
These results suggest that while Salmonella SgrS is stable in the absence of Hfq owing to 
translation of sgrT, it does not efficiently regulate mRNA targets.  In sum, these data 
indicate that in a Δhfq background, S. Typhimurium SgrS is stabilized by translation of 
sgrT, but functions poorly as a riboregulator in the absence of the RNA chaperone.  
Failure to efficiently pair with mRNA targets likely leaves more SgrS molecules 
available for translation, accounting for increased SgrT production from wild-type SgrS 
in the Δhfq mutant background compared to the hfq+ strain (Fig. 3.6A).  Consistent with 
these observations, the E. coli SgrS, which naturally produces very little SgrT due to an 
sgrT translation-inhibitory hairpin structure [147], strictly required Hfq for regulation of 
ptsG mRNA stability (Fig. 3.6B, lane 8) and translation (Fig. 3.6C).  
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3.2.5. Riboregulation of SgrS is necessary for growth rescue of stressed Salmonella 
cells 
The data presented so far suggest that translation of sgrT has a minimal impact on 
riboregulation, whereas base pairing activity limits SgrT production.  We wanted to 
further examine how mutants impaired for either the riboregulation or the translation 
function coped with stress when sgrS alleles were expressed from the S. Typhimurium 
chromosome in response to typical stress signals.  Previously, our group showed that E. 
coli cells require the base pairing function to cope with stress because very little SgrT is 
made from the E. coli SgrS [147].  Since SgrT is produced more abundantly by S. 
Typhimurium SgrS and when expressed ectopically, either base pairing or SgrT 
individually can rescue cells from stress, we suspected that S. Typhimurium cells may 
require only one of the two functions for growth recovery during stress.  To test this 
hypothesis, wild-type S. Typhimurium and strains with the mutations described in Fig. 
3.2—sgrS1 (base pairing mutant), sgrS2 (sgrT start codon mutant) and the negative 
control sgrS3 (base pairing and start codon mutant), were grown in minimal glycerol 
medium and treated with αMG.  Wild-type S. Typhimurium cells and cells expressing 
SgrS2 from the chromosome grew equally well in the presence of αMG (Fig. 3.7).  On 
the contrary, the base pairing-deficient sgrS1 mutant strain exhibited severe growth 
inhibition, comparable to the ΔsgrS and the sgrS3 mutant strains (Fig. 3.7).  These results 
indicated that the base pairing function of SgrS is necessary and sufficient for rescue of 
cells from αMG stress in minimal glycerol medium, whereas natural levels of SgrT 
produced under these conditions could not rescue.  This result suggests that SgrS 
riboregulation plays the primary role in growth recovery from stress induced by αMG.  
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3.2.6. Production of SgrT lags synthesis of SgrS RNA 
In Fig. 3.2B, we showed that SgrT produced constitutively from a plasmid was 
able to rescue cells from stress, independent of the base pairing function, but results in 
Fig. 3.7 demonstrated that SgrT produced from chromosomal sgrS could not confer stress 
relief.  One possible explanation for the discrepancy between phenotypes yielded by 
ectopically-produced SgrT versus SgrT made from the chromosomal locus is that 
constitutive expression provides SgrT prior to the onset of stress.  However, when SgrT is 
produced from chromosomally-encoded sgrS, perhaps there is not enough SgrT present at 
the beginning of stress to prevent αMG entry via PtsG.  To gain insight into this issue, we 
measured SgrT protein and SgrS RNA levels produced from the S. Typhimurium 
chromosome before and after stress induction.  We were unable to detect SgrT made 
from the single chromosomal copy of sgrS with the SgrT antibody, indicating lower 
abundance of SgrT produced here compared to ectopic expression conditions.  However, 
we could detect a functional SgrT-FLAG protein when an allele expressing the epitope-
tagged variant was integrated at the native chromosomal locus (suggesting a higher 
sensitivity of the α-FLAG antibody compared to the α-SgrT antibody).  SgrT-FLAG 
protein and SgrS RNA levels were monitored via Western and Northern blot analyses, 
respectively.  As shown in Fig. 3.8A and quantified in Fig. 3.8B, SgrS RNA levels 
dramatically increased upon addition of αMG (4.9 x 109 to 1.2 x 1012 molecules/ml of 
culture) and remained steady from 20 to 60 minutes after stress induction.  While we did 
not take samples from early time points in this experiment, we have shown previously 
that SgrS accumulates rapidly within 2 minutes of αMG addition [139].  After 60 min., 
SgrS continued to accumulate until cells reached early stationary phase.  SgrT levels were 
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similar to SgrS levels before addition of αMG (5.6 x 109, Fig. 3.8A and quantified in Fig. 
3.8C).  However, upon αMG addition, the amount of SgrT did not significantly increase 
until 40 min. post-stress induction.  At 40 min., SgrT levels increased 10-fold compared 
to the 20 min. time point and remained steady at 60, 120 and 150 mins. after αMG 
addition.  Interestingly, SgrT levels declined significantly (10-fold) at the 180 min. time 
point (7.3 x 10
9
), even though SgrS RNA levels remained elevated at this time point (Fig. 
3.8B and C).  Altogether, we concluded that steady state SgrS:SgrT ratios vary 
significantly over time following induction of stress.  Soon after stress induction, SgrS 
RNA accumulates rapidly relative to SgrT.  This is also the time frame during which 
riboregulation is active [103, 115, 139].  Later, between 40 and 150 min after stress 
induction, SgrT accumulates.  After prolonged stress, SgrT levels fall again, even though 
SgrS RNA levels remain very high.   
3.3. Discussion 
The first part of this chapter describes interactions between the two separate 
functions of the sRNA SgrS.  Ectopic expression of the sgrS alleles that possess only base 
pairing activity or only produce SgrT could both rescue cells from glucose-phosphate 
stress.  When we assessed how each activity impacted the efficiency of the other, we 
found that impairing sgrT translation had no real effect on the ability of SgrS to 
translationally regulate its three known mRNA targets (Figs. 3.3B, 3.11).  In contrast, 
impairing base pairing activity by mutating sgrS nucleotides important for target mRNA 
interactions (Fig. 3.4B) or by mutating the RNA chaperone Hfq (Fig. 3.6A) enhanced 
SgrT production.  These results suggest that the base pairing function is the more robust 
or primary activity of SgrS, as it is just as efficient with or without translation, whereas 
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production of SgrT is limited by the competing riboregulation activity.  Consistent with 
the concept of riboregulation as the primary activity of SgrS, we found that when sgrS 
mutant alleles are expressed from the native chromosomal locus in response to stress, 
mutants defective for riboregulation are severely growth inhibited, similar to sgrS null 
mutants, while mutants defective for SgrT production recover from stress as well as wild-
type cells (Fig. 3.7). 
One possible molecular explanation for the more robust riboregulation activity is 
illustrated in Fig. 3.9.  After an SgrS molecule is synthesized in response to stress, it can 
act as a substrate for translation or as a riboregulator.  An SgrS that is translated to 
produce SgrT can presumably subsequently go on to act as a riboregulator.  However, the 
reverse is not true— instead, an SgrS that becomes a riboregulator (at least for repressing 
targets like ptsG and manXYZ mRNAs) is degraded along with its targets.  Thus, when an 
SgrS molecule is synthesized, it can be utilized in one of two ways: 1) It may act as a 
riboregulator, base pair and be co-degraded along with certain targets; 2) It may act as an 
mRNA and produce SgrT protein.  The first pathway is a dead end for that SgrS 
molecule.  It cannot later be used as a substrate for translation.  Thus, disrupting the base 
pairing function significantly increases the pool of SgrS available to be translated.  The 
second pathway is not terminal.  An SgrS molecule that is translated to make SgrT 
protein can subsequently go on and serve as a riboregulator.  This fits with the 
observation that altering translation properties does not have major effects on SgrS 
riboregulation. 
SgrT, when constitutively expressed ectopically, rescued cells from αMG stress in 
the absence of base pairing activity (Fig. 3.2B), whereas when SgrT was expressed alone 
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from the chromosome (from the base pairing-deficient sgrS1 allele), it was unable to 
rescue cells from glucose-phosphate stress (Fig. 3.7).  This result underscores the 
importance of the SgrS riboregulation activity with respect to promoting growth recovery 
during stress.  Quantitation of SgrS and SgrT levels produced from the chromosomal sgrS 
locus during stress showed that although SgrS and SgrT levels are similar before stress 
induction, upon addition of αMG, SgrS RNA levels increase immediately (in less than 20 
min.) and dramatically (>100-fold), whereas SgrT levels remain lower until a later time 
point (40 min.) and only reach ~10-fold higher than the initial levels.  Taken together, our 
results are congruent with a model in which SgrS RNA first acts primarily on target 
mRNAs to regulate their translation and stability during early stages of glucose-
phosphate stress.  SgrT is produced during later stages of the stress response, presumably 
when riboregulation has reached a steady state.  To put this model in the context of 
cellular physiology during stress, it is worth noting that base pairing and SgrT activity 
both ultimately act to limit uptake of non-metabolizable sugar-phosphates by reducing 
transport capacity.  For αMG, the PtsG (EIICBGlc) protein is the relevant transporter and 
we have shown in E. coli that repression of ptsG translation via SgrS riboregulation is 
absolutely indispensible for recovery from αMG stress [131].  Paradoxically, exposure to 
αMG actually increases ptsG transcription via derepression by the Mlc protein [67, 108].  
Thus, SgrS has a formidable task: To silence ptsG transcripts that are actually being 
synthesized at an enhanced rate under stress conditions.  Given this, perhaps it makes 
sense that the cell’s first priority is stopping new transporter synthesis via SgrS 
riboregulation repressing ptsG translation.  When this is accomplished, SgrS can 
accumulate and molecules not engaged in riboregulation can be translated to produce 
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SgrT.  We have shown that SgrT acts by inhibiting activity of existing PtsG (EIICB
Glc
) 
transporters [146], though the exact molecular mechanism of SgrT activity remains 
unclear.  Our current hypothesis is that SgrT directly interacts with PtsG, and if so, its 
activity probably critically depends on PtsG:SgrT stoichiometry.  Perhaps SgrT is not 
sufficient to rescue cell growth during stress in the absence of base pairing activity 
because it cannot accumulate quickly enough to inhibit an ever-increasing number of 
active PtsG transporters. 
While SgrS-dependent reduction of ptsG mRNA is evident within 2 minutes 
following stress induction and full disappearance of ptsG mRNA occurs within 10 
minutes [139], the riboregulation of other targets takes longer.  For manXYZ mRNA, 
reduced levels are not seen until 10 to 15 minutes post-stress, and full degradation takes 
up to ~30 minutes [115].  Likewise, yigL mRNA does not increase significantly until ~10 
minutes following stress and increased levels of YigL protein do not appear until 20 
minutes post-stress [103]and Wadler and Vanderpool, unpublished).  Moreover, SgrS 
also regulates other mRNA targets by base pairing and the kinetics of these other 
regulatory events have not yet been elucidated (Bobrovskyy and Vanderpool, 
unpublished).  Nevertheless, given the time frame required for regulation of targets like 
manXYZ and yigL, it is reasonable to postulate that the delay in SgrT production is due to 
SgrS engagement as a riboregulator.  However, we cannot rule out the possibility that 
another regulatory mechanism is responsible for impairing SgrT synthesis until later time 
points.  This is an issue that is currently under investigation.  
When SgrT produced from the S. Typhimurium chromosomal sgrS locus was 
measured, we noticed that SgrT levels remained highest between 40 and 150 min. after 
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stress induction (Fig. 3.8A).  However, at the 180 min. time point, SgrT levels decreased 
back to the basal pre-stress levels (Fig. 3.8A and 3.8C).  Decreased SgrT in later stages of 
stress may reflect reduced PtsG levels at this time if SgrT stability is tied to its interaction 
with PtsG.  Supporting the idea that SgrT is unstable in the absence of PtsG, we could not 
detect ectopically-expressed SgrT in a ΔptsG mutant strain (data not shown) even though 
it was readily detected in ptsG
+
 strains (Figs. 3.4B, 3.5B and 3.6A).  Along with our 
collaborators, we recently observed that upon αMG treatment of S. Typhimurium cells, 
although SgrS accumulated immediately and stopped synthesis of new PtsG, PtsG protein 
levels had declined by only ~2-fold at 80 min. after αMG treatment [103] suggesting that 
the reduction in PtsG levels is not due to active turnover but instead passive dilution by 
cell growth.  We suggest that the later time points in our experiments (after 150 min.) 
correspond to greatly reduced PtsG protein levels leading to instability of SgrT.  
 The implication that SgrS base pairing and SgrT act at different stages of the 
stress response raises questions about the nature of glucose-phosphate stress itself.  Our 
previous hypothesis was that SgrT would be produced immediately to inhibit uptake of 
potentially toxic sugar-phosphates while the base pairing activity would provide a longer-
term adaptation to stress by preventing continued synthesis of transporters.  Instead, our 
data suggest that stopping new PtsG synthesis by regulating ptsG mRNA is the first order 
of business for SgrS, and that PtsG transporters present at the onset of stress might 
remain active until SgrT is produced after prolonged stress.  The idea that stopping new 
PtsG synthesis is essential for growth rescue is upheld by other recent work from our 
laboratory where we demonstrated that an sgrS mutant defective specifically for ptsG 
silencing (but competent for regulation of other mRNA targets) had the same growth-
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inhibited phenotype as an sgrS null mutant during αMG stress [131].  Other work aiming 
to uncover the metabolic deficits experienced by stressed sgrS mutant cells revealed that 
growth inhibition is not strictly tied to intracellular αMG concentrations [117].  Rather, 
stress-related growth inhibition of sgrS mutants seems to be due to depletion of glycolytic 
intermediates, particularly PEP, during unregulated transport of αMG, a substrate that 
cannot be metabolized to replenish these intermediates [117].  Taking these observations 
in the context of the current work, it seems possible that the cell can tolerate some level 
of αMG uptake and depletion of metabolic intermediates as long as SgrS base pairing 
activity prevents the problem from getting worse, i.e., by immediately limiting 
production of new transporters.  Viewed this way, perhaps it makes sense that SgrT is 
only produced later once the base pairing activity has reached its maximal effect, in order 
to more completely shut down the uptake of αMG.  Work is ongoing to test these 
hypotheses regarding the timing of the two SgrS functions and their relative roles in 
reducing αMG uptake and central metabolite depletion.  These studies provide a 
foundation for understanding how a small RNA regulator with two functions coordinates 
these functions to produce a successful stress response.   
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3.4. Figures 
 
 
Figure 3.1. The S. Typhimurium sgrS and sgrT sequences. S. Tyhpimurium sgrS is 
239 nt in length.  The 41 amino acid SgrT sequence is shown below the sgrS RNA 
sequence.  The transcription start site of sgrS is denoted by “+1”.  The ribosome binding 
site of sgrT is underlined and marked as “RBS”.  The start and the stop codons of sgrT 
are boxed.  The highly conserved sequences involved in base pairing with ptsG mRNA 
are indicated by the dashed box.  The inverted repeat of the SgrS intrinsic terminator is 
indicated by arrows.   
  
GAUGAAGCAAGAGGAAGAGGUCACUAUGCGCCAGUUCUGGUUGAGAUAUU 
                         M  R  Q  F  W  L  R  Y  F  
UUGCCGCGACGGAAAAAACGUCCUGGCUGGCUUGCCUGAGCGCACCGCAG 
  A  A  U  E  K  U  S  W  L  A  C  L  S  A  P  Q   
CGCUUAAAAAUGCUCGCGGAACUGAUGCAGUGGGAGGCGACCGAUUGAAG 
R  L  K  M  L  A  E  L  M  Q  W  E  A  U  D  *       
CCAAUUGCAGACAUCAUGUGUGACUGAGUAGAGUAUUGGUGUAGGCGAUA 
  
GCCUAAAAUCACCCGCCAGCAGAUAAUAUCUGCUGGCUUUUUUU 
RBS+1
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Figure 3.2. Description and phenotypic analysis of sgrS mutants.  A) The sgrS alleles 
used in this study.  Construction of the alleles is described in detail in Materials and 
Methods.  Functional features of different sgrS mutants are described in detail in the text.  
B) A ΔsgrS S. Typhimurium strain (DB111) carrying the plasmid vector (pBRCS12), or 
plasmids with S. Tyhimurium wild-type sgrS (pBRCS22), sgrS1 (pBRCS27), sgrS2 
(pBRCS30) or sgrS3 (pBRCS31) alleles (described in Fig. 2A and text) were grown to 
early-logarithmic phase in M63 minimal medium with glycerol. αMG was added at a 
final concentration of 0.5% and growth was monitored over time until cultures reached 
stationary phase.  The graph shown is a representative of 4 independent experiments.  C) 
The constructs described in Fig. 2A were grown in M63 glycerol overnight and 
subcultured into M63 glucose.  Growth was monitored over time until cultures reached 
stationary phase.  The graph shown is a representative of 3 independent experiments. 
     
  
Name  Description of alleles  
sgrS  Wild-type  
sgrS1  Two point mutations that impair base pairing activity 
sgrS2  Mutated sgrT start codon  
sgrS3  Combined mutations from sgrS1 and sgrS2  
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Figure 3.3. Description and analysis of sgrS alleles with mutations in sgrT 
translation initiation region.  A) Mutations in the sgrT translation initiation region are 
indicated.  The sgrS19 and sgrS20 alleles have an extensively mutated sgrT RBS and 
start codon.  The sgrS21 and sgrS22 alleles have deletions in the spacer region between 
the RBS and the start codon, and sgrS23 has the AUG start codon mutated to a GUG start 
codon.  B) Cultures of JH111 (ΔsgrS lacIqtetR) harboring the plasmid carrying Plac-ptsG′-
′gfp (pZEDB03) and a compatible plasmid (pZA-plasmid series) with the Ptet-sgrS alleles  
indicated in A were growth to mid-logarithmic phase and expression of ptsG′-′gfp and 
SgrS induced with 0.75mM IPTG and 30ng/ml aTc, respectively.  Black bars represent 
cultures with only the translational fusion induced (-SgrS).  Gray bars represent cultures 
having both the translational fusion and the sgrS allele induced (+SgrS).  Kinetic 
fluorescence assays were performed, and the Relative Fluorescence Units (RFU) were 
measured and normalized to culture density (OD600).  The RFU/OD600 value of cultures 
that only induced for the translational fusion was normalized to 1.  
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Figure 3.4. Comparison of SgrS and SgrT levels produced by wild-type and base 
pairing-deficient sgrS alleles. A) Cultures of JH111 containing the plasmid vector 
(pBRCS12), S. Typhimurium wild-type sgrS plasmid (pBRCS22) or sgrS1 plasmid 
(pBRCS27) were grown to mid-logarithmic phase.  Transcription of Plac-sgrS alleles was 
induced with 1mM IPTG and total RNA was harvested 20 min. later.  Total RNA was 
subjected to Northern blot analysis, probing for SgrS and subsequently for SsrA RNA 
(loading control).  B) Total protein was harvested from the same cultures at the same time 
and analyzed by Western blot using an -SgrT antibody.  The cross-reacting bands above 
SgrT served as loading controls for quantification purposes.  The software ImageJ was 
used to quantitate SgrS and SgrT expression from the different alleles, and were 
normalized relative to wild-type SgrS and SgrT levels.  
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Figure 3.5.  Comparison of SgrS and SgrT levels produced by wild-type and base 
pairing-deficient sgrS alleles in a degradosome mutant host.  Cultures of the wild-type 
(JH111) or the rne131 mutant (DB148) strain containing the Plac-plasmid vector or 
plasmids with S. Typhimurium wild-type sgrS (pBRCS22) or sgrS1 (pBRCS27) were 
grown to mid-logarithmic phase and transcription of sgrS was induced with 1mM IPTG.  
A) Total RNA was harvested 20 min. after IPTG addition and analyzed as described in 
Fig. 3.4.4A.  B) Total protein was extracted at the same time as RNA and was subjected 
to Western blot as described in Fig. 3.4.4B.  The cross-reacting bands above SgrT served 
as loading controls for quantification purposes.  The software ImageJ was used to 
quantitate SgrS and SgrT.  Amounts produced by strains carrying SgrS1 were normalized 
relative to amounts produced by strains carrying wild-type SgrS (set at 1.0). 
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Figure 3.6. (cont.) 
 
Figure 3.6.  Analysis of SgrS levels and the efficiency of riboregulation in wild-type 
and hfq mutant strains.  A) Wild-type (JH111) and Δhfq (DB138) strains containing the 
Plac-plasmid  vector (pBRCS12) or plasmids with S. Typhimurium wild-type sgrS 
(pBRCS22) or sgrS19 (pBRDB12) were grown to mid-logarithmic phase.  Transcription 
of sgrS alleles was induced with 1mM IPTG and total protein was harvested after 20 min. 
and subjected to Western blot analysis using an -SgrT antibody.  The cross-reacting 
bands above SgrT served as loading control for quantification purposes.  The software 
ImageJ was used to quantify SgrS and SgrT levels as described in Fig. 5B.  B) JH111 and 
DB138 strains carrying the vector (pBRCS12), S. Typhimurium wild-type sgrS 
(pBRCS22), translation-deficient sgrS19 (pBRDB12) or the E. coli wild-type sgrS 
(pLCV1) were grown to mid-logarithmic phase.  Transcription of sgrS was induced as 
described in part A and total RNA was harvested and subjected to Northern blot analyses 
probing for SgrS or ptsG RNAs or SsrA RNA (loading control).  ImageJ was used to 
quantify the intensities of SgrS and ptsG bands.  The amount of wild-type S. 
Typhimurium SgrS in the hfq+ strain was set at 1.0 and SgrS levels in other samples were 
normalized to this.  The amount of ptsG mRNA in hfq+ cells carrying the vector control 
was set at 1.0 and levels in all other samples were normalized to this.  C) Strains 
containing the ptsG′-′lacZ fusion in an hfq+ (JH258) and hfq (DB151) background 
carrying the vector, S. Typhimurium wild-type sgrS (pBRCS22), sgrS19 (pBRDB12) or 
the E. coli wild-type sgrS (pLCV1) were grown to mid-logarithmic phase.  Transcription 
of sgrS was induced with 0.1 mM IPTG for 60 minutes and then cultures were assayed 
for β-galactosidase activity as described in Materials and Methods.   
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Figure 3.7.  Expression of wild-type and mutant sgrS alleles from the Salmonella 
chromosome and analysis of growth during stress. Cultures of S. Typhimurium with 
sgrS alleles at the native locus: wild-type SgrS (DB108), ΔsgrS (DB111), sgrS1 (DB140), 
sgrS2 (DB142) or sgrS3 (DB143) were grown to mid-logarithmic phase in M63 glycerol 
medium.  All cultures were treated with αMG at OD600 of ~0.1, and growth was 
monitored over time.  
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Figure 3.8. Quantitation of SgrS and SgrT levels over a time course following stress 
induction.  A) S. Typhimurium cells containing a sgrT-3X FLAG construct (DB153) 
were treated with αMG at an OD600 of ~0.1, and total RNA and protein samples were 
simultaneously extracted at the time points indicated.  The RNA and protein samples 
were subjected to Northern and Western blot analyses probing for SgrS and FLAG, 
respectively.  B) Serial dilutions of known amounts of in vitro transcribed SgrS (in µg) 
were loaded on gels simultaneously with total RNA from each time point described in 
part A, subject to Northern blot, probed with biotinylated SgrS probe and quantified 
using IMAGEJ.  Standard curves were first derived from the known quantities of in vitro 
transcribed SgrS.  Levels of SgrS from each time point in Fig. 8A were quantified (in µg) 
based on the standard curve, then the number of molecules of SgrS/ml of culture was 
calculated.  The arrow indicates addition of αMG after the 0 min. time point.  C) Serial 
dilutions of known amounts of the BAP-FLAG protein (in ng) were loaded on gels 
simultaneously with protein from each time point described in part A, subjected to 
Western blot, probed with FLAG and quantified using IMAGEJ.  Standard curves were 
first derived from the known quantities of BAP-FLAG protein.  Levels of SgrT from each 
time point in Fig. 8A were quantified (in ng) based on the standard curve and thus the 
number of SgrT molecules/ml of culture was calculated.  The arrow indicates addition of 
αMG after the 0 min. time point.  
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Figure  3.9.  Model for SgrS and SgrT activities in S. Typhimurium.  The model is 
discussed in detail in the text.   
 
 
 
Figure  3.10.  Levels of SgrS RNA from wild-type and translation-impaired sgrS 
alleles.  Wild-type (JH111) cells containing the Ptet-sgrS alleles described in Fig. 2A and 
Fig. 3A were grown to mid-logarithmic phase, induced with 30ng/ml aTc and total RNA 
extracted 20 min. after induction.  The samples were subjected to Northern blot using a 
biotinylated SgrS probe.  
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 Figure  3.11.  Translational regulation of manX  (top) and yigL (bottom)  by wild-
type and translation-impaired sgrS alleles.  Cultures of JH111 harboring the plasmid 
carrying Plac-manX′-′gfp (pZEMB11) and  Plac-yigL′-′gfp (pZEMB15) and a compatible 
plasmid with the Ptet-sgrS alleles indicated in A were growth to mid-logarithmic phase 
and expression of manX′-′gfp,  yigL′-′gfp and SgrS induced with 0.75mM IPTG and 
30ng/ml aTc, respectively.  Black bars represent cultures having only the translational 
fusion induced (-SgrS).  Gray bars represent cultures having both the translational fusion 
and the sgrS allele induced (+SgrS).  Kinetic fluorescence assays were performed, and 
the Relative Fluorescence Units (RFU) were measured and normalized to culture density 
(OD600).  The RFU/OD600 value of cultures that only induced for the translational fusion 
was normalized to 1.  
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Chapter 4: Post-transcriptional regulation of central metabolism 
 by the small RNA DicF 
4.1. Introduction 
 The DicF sRNA was discovered in the late 1980s by the observation that 
overproduction of DicF in E. coli cells leads to inhibition of cell division and 
filamentation [13, 133].   It is produced from a polycistronic transcript, called the dicBF 
operon, consisting of five open reading frames (ORFs) and a sRNA, with a single, 
confirmed promoter [34, 35].  The other characterized gene in this operon is the DicB 
protein, which is located after DicF and also inhibits cell division [16, 34].  The only 
postulated target of DicF is the ftsZ mRNA, whose protein product forms the septal ring 
during cell division in bacteria [133].  DicF is an interesting example of a horizontally 
acquired DNA element that presumably regulates ftsZ mRNA in a negative manner.  
There are other examples of sRNA-mediated interactions between phage elements and 
the host genome.  For example, SgrS, encoded on the core genome of Salmonella, 
regulates the sopD mRNA produced from a foreign genomic element [101].  In contrast, 
DicF is an example of a sRNA encoded on a prophage that seems to regulate at least one 
host gene.  In addition, DicF also interacts with several host protein complexes.  The 
ribonucleases RNase E and RNase III are involved in cleavage and release of DicF from 
the dicBF operon [34] .  Similar to many core E. coli sRNAs, DicF has also been shown 
to bind the RNA chaperone, Hfq [159].  Therefore, DicF serves as a useful model to 
study the evolution of regulatory networks of a phage-encoded sRNA and its impacts on 
cell physiology.  
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 The Qin prophage that contains the dicBF operon is one of nine defective phages 
in E. coli [11, 17].  Temperate phages that are integrated into the bacterial host are called 
prophages. Some prophages retain the ability to excise out of the host chromosome under 
conditions triggering lytic growth and are considered to be active [21], whereas others are 
permanently a part of the bacterial chromosome due to their inability to leave the host 
genome, usually due to partial deletions at the phage genome.  The latter are called 
defective or cryptic prophages and are in a state of gradual decay in E. coli [17].  
Bacterial prophages can be parasitic or mutualistic to the host they reside in.  Intact 
temperate phages can go through the lytic life cycle every so often, thereby killing the 
host and imposing a fitness cost on the bacterium [43]. In contrast, a number of 
prophage-encoded genes are beneficial to the host [23, 65, 86, 149].  The well 
characterized SodCI protein (super oxide dismutase) produced in Salmonella species [44, 
149[Los, 2012 #646] and the cholera toxin synthesized by Vibrio cholera are encoded by 
prophages present in the respective species [33, 66]. These two models that portray 
prophages as beneficial to the host or seen to have detrimental effects on the host are not 
mutually exclusive.  In other words, a DNA element on a prophage that was originally 
used to kill the host can be retained to become beneficial to the bacterium under certain 
conditions.  This especially applies to cryptic prophages, which retain some of the 
original prophage genes, but lose others required for excision of the phage from the 
genome.  Consistent with this idea, genes encoded on cryptic prophages that are 
otherwise lethal to the host, have been shown to protect the host against oxidative stress, 
acid treatment and low doses of antibiotics [152].  Thus, seemingly dormant and/or toxic 
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genes encoded by prophages are retained due to their significant physiological benefits 
during harmful environmental conditions.    
The goals of this chapter are two-fold.  First, we aim to understand regulatory 
networks of the sRNA DicF in the host E. coli genome and transcriptome. Although the 
sRNA DicF was identified as an RNA regulator in the late 1980s, only one potential host 
target has been found thus far.  Towards this goal, we use computational predictions and 
RNA-Seq analyses on E. coli cells expressing DicF from a multi-copy plasmid to identify 
potential host targets of DicF.  Genetic analyses demonstrate that in addition to post-
transcriptionally regulating ftsZ, DicF also regulates three genes in central metabolism: 
xylR, pykA and pfkA.  We also present evidence that overproduction of DicF not only 
causes cell filamentation, but also leads to growth inhibition.  The second goal of this 
study is to begin to understand how prophage elements in the so-called cryptic prophages 
modulate host metabolism to be parasitic or beneficial to host physiology.   Using the 
dicBF operon as our tool for understanding this, we demonstrate that the DicF and DicB 
functions in the cell are additive; production of both these toxic molecules together are 
severely harmful to E. coli cells compared to expression of these genes individually.   
4.2. Results 
4.2.1. The genes xylR, pykA and pfkA are post-transcriptionally regulated by DicF 
Two approaches were undertaken to characterize the DicF regulon.  First, four 
computational programs, namely Target RNA [135], IntaRNA[15], CopraRNA[156] and 
Starpicker [157], were used to generate a list of potential DicF targets.  Second, whole 
genome RNA-Seq analyses were conducted on the E. coli ΔdicF genome harboring 
plasmids Plac-vector or Plac-dicF.  We hypothesized that RNA-Seq analyses would 
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potentially help us identify mRNA targets of DicF that are affected at the level of their 
stability.  The transcription profiles of cells expressing the vector or DicF were compared 
using the program Rockhopper [84].  Genes that were significantly differentially 
regulated (q-value of ≤0.05) were categorized functionally. Several genes in sugar uptake 
and central metabolism were differentially expressed in response to DicF. To investigate 
whether these target genes were post-transcriptionally regulated by DicF, we constructed 
translational lacZ fusions to the genes listed in Table 4.1.  For each fusion, the 5′ 
untranslated region (UTR) and 10-20 amino acids of coding sequence (CDS) were 
recombined into a heterlogous locus containing an inducible, PBAD promoter [79] to 
remove any indirect transcriptional effects of DicF (Fig. 4.1A).   Translational regulation 
of the reporter gene fusions was measured by β-galactosidase assays.  As shown in Fig. 
4.1, many gene fusions were moderately regulated by DicF.  Targets whose expressions 
were repressed ≥ 2-fold or enhanced ≥1.75-fold were chosen for future study.  Thus, the 
genes xylR, pykA and pfkA were determined to be post-transcriptionally regulated by 
DicF (Fig. 4.1B).  
4.2.2. xylR, pykA and pfkA are post-transcriptionally regulated even in the absence 
of chromosomal Qin 
 RNA-Seq analyses indicated that the expression profiles of several genes within 
the Qin prophage were significantly up-and down-regulated in response to DicF (data not 
shown).  To eliminate indirect effects of xylR, pykA and pfkA by other genes in the Qin 
prophage, we deleted qin and tested the effect of DicF overexpression on target 
regulation.  As shown in Fig. 4.2, xylR, pfkA and pykA were regulated to similar levels in 
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the presence and absence of chromosomal qin. This result excluded the possibility that 
the regulation of the targets were indirectly regulated by elements within the prophage.   
4.2.3. Genetic and molecular characterization of DicF-xylR interactions 
 Characterization of DicF-xylR interactions: XylR is a transcription factor 
involved in uptake of D-xylose into the cell and in catabolim of xylose.  It activates the 
expression of the xylFGH genes whose protein products form the xylose ABC 
transcporter [127] .  XylR also transcriptionally activates the xylAB operon.  The XylA 
and XylB proteins are involved in catabolism of xylose once they are brought into the 
cell.   
 DicF was originally identified as a cell division inhibitor.  The mechanism by 
which it inhibits cell division was hypothesized to be by its repression of ftsZ translation  
[133].  We began characterizing DicF-xylR interactions by studying and validating the 
base pairing requirements of DicF to regulate both ftsZ and xylR.  
 Base pairing requirements of DicF to xylR versus ftsZ: Consistent with previous 
studies implying ftsZ as a post-transcriptional target of DicF, we found that 
overproduction of DicF repressed expression of a translational ftsZ′-′lacZ fusion (Fig. 
4.3B).  To characterize the base pairing interactions of DicF with ftsZ and with xylR, base 
pairing predictions were conducted using the program IntaRNA.  The 3′ region of DicF 
was predicted to interact with the ftsZ mRNA at its ribosome binding site (RBS) (Fig. 
4.3A).  In contrast, the more 5′ region of DicF was postulated to bind xylR.  To verify 
these predictions, two sets of residues were mutated in dicF, producing dicF3 and dicF9.  
The dicF3 mutation was made to abolish DicF-xylR interactions, whereas the dicF9 
mutation was postulated to abrogate DicF-ftsZ pairing (Fig. 4.3A).  Consistent with our 
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base pairing predictions, DicF3 no longer regulated xylR but still regulated ftsZ 
expression, and DicF9 did not regulate ftsZ but regulated xylR (Fig. 4.3B).  These 
mutational analyses suggested that DicF interacts with xylR and ftsZ using different base 
pairing residues.  To further confirm the interactions between DicF and the ftsZ mRNA, 
additional mutagenesis was conducted on both dicF and ftsZ (Fig. 4.3C).  The DicF RNA 
expressed from the alleles dicF14, 15 and 16 abrogated regulation of ftsZ to different 
levels (Fig. 4.3D).  DicF15 partially abolished ftsZ regulation.  To verify this interaction 
region further, a compensatory mutation was constructed in the ftsZ reporter gene fusion 
(ftsZ15) such that ftsZ would no longer pair with wild-type DicF, but should restore base 
pairing with dicF15 (Fig. 4.3C).  Consistent with our hypothesis, wild-type DicF no 
longer regulated ftsZ15, whereas DicF15 partially restored this regulation (Fig. 4.3E), 
suggesting that the predicted DicF-ftsZ interactions are indeed true.   
 Mutational analyses of DicF-xylR interactions:  Using the same approach 
described above to characterize DicF-ftsZ interactions, we first predicted a region of 
complementarity between DicF-xylR.  DicF was predicted to bind in the coding sequence 
of xylR, 5 nucleotides downstream of the start codon.  To validate these interactions, the 
3′ coding region of xylR was truncated to 1 amino acid in the context of the reporter gene 
fusion, yielding xylR-3′trunc.  Wild-type DicF no longer regulated this fusion as expected 
(Fig. 4.3G).  Next, a mutant of dicF, dicF11 (Fig. 4.3F), was isolated that abolished 
partial regulation of the original xylR fusion (Fig. 4.3G).  To compensate for the dicF11 
abrogation of xylR regulation, a mutation was constructed in the xylR reporter fusion, 
yielding xylRcomp11 (Fig. 4.3F).  Consistent with our base pairing predictions, wild-type 
DicF did not regulate xylRcomp11, but DicF11 was able to regulate this fusion (Fig. 4.3G).  
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These genetic analyses demonstrated the base pairing interactions between DicF and xylR 
to be in the coding sequence of xylR.   
 Degradosome assembly is dispensable for xylR regulation, whereas Hfq is 
necessary:  Several sRNAs have been shown to bind Hfq [27, 92, 98, 145].  As shown in 
Chapter 3, Fig. 3.6., Hfq is important for its stable expression and for regulation of targets 
by SgrS[5].  DicF has been shown to bind to Hfq with lower affinity than other sRNAs 
[98], but the role of Hfq in regulation of targets has not been studied.  Similarly, 
degradosome assemble by RNase E has been demonstrated to be important for regulation 
of small RNA-mediated regulation of some targets [25, 39, 107].  Requirements of 
neither of these protein complexes have been shown for DicF-target interactions.  In 
addition, since DicF is encoded on a horizontally acquired DNA element, the importance 
of these host proteins affecting DicF functionality is crucial to test.  We tested regulation 
of xylR in the context of the rne131 mutant [73] that is defective in mRNA degradation 
and in an hfq deletion background, respectively.  As shown in Fig. 4.4A, xylR was 
regulated 10-fold in a wild-type background.  Introduction of the rne131 mutant in the 
context of this fusion had no effect on xylR regulation, whereas deleting hfq completely 
abolished its regulation. This result suggested that while Hfq is necessary for DicF-
mediated regulation of xylR, degradosome assembly is dispensable.   
 Consistent with the expendable role of degradosome assembly in xylR regulation, 
we observed that xylR mRNA levels (expressed from a constitutive Cp19-promoter) 
remained unchanged upon DicF over expression (Fig. 4.4B), suggesting that the primary 
mechanism of xylR regulation is at the level of translation and not stability.   
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 Physiological consequences of DicF-xylR interactions: Next, we sought to 
understand the physiological consequences of DicF-xylR pairing.  Since XylR is a 
transcriptional factor that activates expression of genes involved in xylose uptake and 
catabolism [127], we postulated that repression of xylR by DicF might affect growth of E. 
coli in minimal medium with xylose as the sole carbon source.  Cells that lack a 
chromosomal xylR are unable to grow on minimal xylose medium, whereas their growth 
is uninhibited in LB ([127] and Fig. 4.5).  Expression of DicF is toxic to E. coli cells and 
affects the colony formation ability of E. coli on both LB and xylose agar plates (Fig. 
4.5).  To differentiate the ability of DicF to restrict growth of E. coli in xylose medium 
from its repression of cell division, we utilized mutants of dicF that do not regulate ftsZ 
or do not regulate xylR respectively.  Expression of DicF3 inhibited growth of E. coli 
cells in LB and xylose medium.  This was expected because this mutant only abolishes 
regulation with xylR, but ftsZ is still regulated by DicF3 (Fig.4.3B).  In contrast, DicF9 
does not interact with ftsZ, but still base pairs and regulates xylR expression (Fig. 4.3B).  
Expression of DicF9 did not affect growth on LB, but still inhibited growth of cells on 
xylose plates (Fig. 4.5).  Taken together, these results suggested that DicF affects growth 
of E. coli on xylose independently of its effect on cell division.  Therefore, DicF 
functions to inhibit cell division and prevent growth of E. coli in xylose medium.   
4.2.4. Characterization of DicF-pfkA interactions 
 PfkA catalyzes the important, irreversible step in glycolysis, catalyzing the 
phosphorylation of fructose-6-phosphate.  Several metabolic pathways feed into fructose-
6-phosphate.  The pentose-phosphate pathway feeds into glycolysis at this step. In 
contrast to regulation of the other two targets, PfkA expression is enhanced by DicF.   
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 Base pairing requirements of DicF-pfkA interactions: We used IntaRNA to predict 
a pairing site for DicF-pfkA base pairing interactions.  The only pairing site predicted by 
this program and by sequence gazing is the region surrounding the RBS of pfkA (Fig. 
4.6A).  If this base pairing prediction was true, then we would expect mutations in dicF 
pairing site to abrogate pfkA regulation.  Indeed, several mutations in dicF abrogating 
pairing with pfkA could be isolated (Fig. 4.6B).   
 Lastly, we also observed an increase in pfkA mRNA levels 20 mins after DicF 
overproduction compared to the overexpression of the vector control (Fig. 4.6D).   
 Degradosome assembly is dispensable for pfkA regulation, but Hfq is necessary: 
After confirming the base pairing sequences involved in DicF-pfkA pairing, we tested the 
requirement of degradosome assembly and the RNA chaperone Hfq in regulation of pfkA. 
Using the rne131 mutant and the Δhfq mutant in the pfkA′-′lacZ fusion background, we 
tested regulation of pfkA in response to DicF expression from the Plac plasmid (Fig. 4.6C).  
Similar to xylR, pfkA was upregulated equally in both a wild-type and the rne131 
background.  In contrast, pfkA regulation was nearly completely abolished in the absence 
of chromosomal hfq (Fig. 4.6C).   
4.2.5. Characterization of DicF-pykA interactions 
 PykA is an important enzyme in glycolysis that is conserved in several organisms 
from bacteria to humans.  In E. coli, pykA is one out of two pyruvate kinase enzymes that 
catalyzes the last step of glycolysis, converting pyruvate to phosphoenolpyruvate.   
 Base pairing requirements of DicF-pykA interactions:  A region of 
complementarity was identified between DicF and pykA using the program IntaRNA.  
The predicted interactions between DicF and pykA involved pykA residues surrounding 
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the RBS and start codon of pykA (Fig. 4.7A).  To validate this binding site, we tested 
several mutants of DicF on pykA regulation.  As shown in Fig. 4.7B, dicF8 and dicF9 
abolished repression of pykA, confirming our predictions for DicF-pykA interactions.  
 Degradosome assembly is dispensable for pykA regulation, but Hfq is necessary: 
We tested the role of degradosome assembly and the requirement of Hfq in regulation of 
pykA.  Using the rne131 mutant and the Δhfq mutant in the pykA′-′lacZ fusion 
background, we tested regulation of pykA in response to DicF expression from the Plac 
plasmid (Fig. 4.7C).  Similar to xylR and pfkA regulation, pykA was regulated equally in 
both a wild-type and the rne131 background.  In contrast, pykA regulation was nearly 
completely abolished in the absence of chromosomal hfq (Fig. 4.7C).   
 The pykA mRNA is degraded in response to DicF over expression:  Since 
translation of pykA was silenced even in the rne131 mutant, we postulated that the 
primary mechanism by which DicF regulates pykA is by inhibiting its translation.  To 
determine if pykA mRNA stability was affected by DicF expression, we conducted 
Northern blot analyses on pykA mRNA during DicF over expression.  pykA mRNA was 
monitored in a strain in which the native pykA promoters were replaced with a 
constitutive Cp19 promoter, to eliminate any transcriptional effects of DicF on pykA 
mRNA.  As shown in Fig. 4.7D, pykA stability decreased during DicF over expression in 
contrast to cells expressing the Plac-vector. This result suggested that DicF regulates pykA 
by a contrasting mechanism than how it regulates xylR.   
4.2.6. Expression of DicF inhibits both cell division and growth of E. coli 
 After establishing the three targets of DicF in central metabolism, we wanted to 
understand the toxicity mediated by DicF.  To do so, we isolated mutants of DicF 
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impaired in regulation of some targets, but not others.  RNA produced from dicF3 
mutation abolished repression of xylR and pykA, but still regulated ftsZ and pfkA (Fig. 
4.8A), whereas the DicF21 RNA abolished regulation of pykA, ftsZ and pfkA, but retained 
the ability to silence xylR translation (Fig. 4.8A).  Next, we tested the ability of these 
mutants to inhibit colony formation of E. coli cells.  Upon induction of the plasmids 
carrying the Plac-vector, Plac-dicF or its mutants with IPTG, cells expressing wild-type 
dicF or dicF3 were unable to form isolated colonies on LB agar plates, whereas 
expression of vector or dicF21 did not affect ability of cells to form colonies (Fig. 4.8B).  
This was expected because both wild-type dicF and dicF3 repress ftsZ translation, which 
in turn causes filamentation of E. coli cells, whereas DicF21 does not regulate ftsZ (Fig. 
4.8A and 4.8E).  The overall decrease in FtsZ protein levels in host cells by DicF and 
DicF3 impaired their colony formation ability.   
To identify the toxic effects of DicF in liquid medium, we used cells expressing 
the same mutants described above.  Expression of the wild-type DicF or the mutant DicF 
RNAs was induced when cells reached on OD600 or ~0.1.  Compared to cells expressing 
the vector control and the negative control DicF21, E. coli expressing DicF were severely 
growth inhibited (Fig. 4.8C).  Since the DicF3 mutant still inhibited ftsZ (Fig. 4.8A) and 
clearly caused extensive filamentation of cells even within 1 hour of induction (Fig. 
4.8E), we postulated that cells expressing DicF3 would also be growth inhibited.  
However, surprisingly, DicF3 only moderately affected growth and mostly during 
stationary phase (Fig. 4.8C).  Wild-type DicF not only caused inhibition of septation but 
also led to a bloated morphology of cells (Fig. 4.8E).  Expression of DicF3 simply 
seemed to cause filamentation without affecting any other observable cell morphology 
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(Fig. 4.8E), suggesting that DicF3 is deficient in regulating an unknown target(s) that 
confers extensive toxicity to host cells. Although DicF3 does not regulate xylR and pykA, 
de-repression of these targets is most likely not the cause of the relief from DicF toxicity, 
as the experiments were conducted in LB medium where xylR and pykA have no growth 
phenotypes [4] .  Moreover, expression of wild-type DicF caused bloating of cells, 
whereas DicF3 expression simply seemed to cause filamentation (Fig. 4.8E). We predict 
that there are other targets of DicF relating to cell shape or peptidoglycan that combined 
with the ability of DicF to inhibit cell division results in severe toxicity leading to growth 
inhibition of E. coli cells. Lastly, we also observed that overproduction of DicF does not 
cause cell lysis (Fig. 4.8D).  Cell survival was measured by measuring the colony 
forming units (CFU/ml) of E. coli before and after induction of DicF (indicated by 
asterisks in Fig. 4.8C).  While we saw a 20-fold increase in CFU/ml during expression of 
vector (corresponding to the increase in OD600 in Fig. 4.8C), we only saw a moderate 
drop in CFU/ml (<8-fold) when we overexpressed DicF (Fig. 4.8D). Moreover, in our 
microscopy experiments, we did not see visible lysis of cells during DicF overproduction 
(Fig. 4.8E).  Therefore, we concluded that while expression of DicF inhibits cell division 
and growth, it most likely does not participate in cell lysis.  
4.2.7. DicF and DicB act in synergy to cause cell toxicity 
 After examining the toxic effects of DicF in E. coli, we wanted to understand how 
DicF and DicB contribute to cell toxicity when expressed from their native locus.  Since 
the mechanism by which the dicBF operon is induced is still unknown, we inserted an 
inducible, Plac promoter replacing the Plac-dicBF promoter, thus abolishing repression 
mediated by DicA and DicC.  Then, the dicF or the dicB gene was deleted as described 
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before [31], leaving only a frt-scar sequence at each of the site (Fig. 4.9A).  We then 
assayed for the growth of these strains in LB agar and liquid medium upon induction of 
the operon.   Induction of the Plac-dicBFoperon caused cells to be very sick and in fact no 
growth was observed on plates (Fig. 4.9B).  Deletion of dicF and dicB in the context of 
this inducible operon still rendered the cells sick, although the ΔdicF strain was more 
growth inhibited and had many suppressor colonies compared to the ΔdicB strain (Fig. 
4.9B).  Lastly, expression of the operon containing deletions of both dicF and dicB did 
not affect cell growth, indicating that dicF and dicB caused the majority of toxicity on 
agar plates.  In liquid medium, we observed that even in the absence of the inducer, the 
Plac-dicBF strain was growth inhibited (data not shown).  We concluded that this was due 
to the leakiness of the promoter.  Therefore, a wild-type E. coli strain (containing the 
intact native promoter of the dicBF operon) was used as a control.  Induction of the Plac-
dicBF operon was severely growth inhibitory; cells expressing this operon grew upto an 
OD600 of ~0.2, and then we observed a decrease in optical density over time.  The ΔdicF 
strain in the context of the inducible promoter is still growth inhibited, but not as severely 
as during induction of the entire intact operon (Fig. 4.9B).  This strain also exhibited a 
drop in optical density over time after cells initially reached an OD600 of ~0.4.  Deletion 
of dicB also inhibited growth of cells compared to the wild-type DJ480 strain.  However, 
ΔdicB cells were less growth impaired compared to the ΔdicF strain or the strain 
containing both intact genes. This suggested that most of the toxicity conferred by this 
operon is probably due to DicB action.  Lastly, expression of the operon in which both 
dicF and dicB was not growth inhibitory.  In sum, we concluded that both dicF and dicB 
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are toxic to E. coli cells, and that their growth inhibitory properties additively cause 
growth inhibition of cells.   
4.3. Discussion 
In this chapter, we undertook studying the prophage encoded DicF sRNA in E. 
coli, previously only known to be a cell division inhibitor.  We demonstrated that DicF 
can post-transcriptionally regulate three genes in central metabolism, namely xylR, pykA 
and pfkA (Fig.4.1B).  DicF-mediated regulation of these targets requires the presence of 
the RNA chaperone Hfq in vivo, but assembly of the degradosome is dispensable (Figs. 
4.4A, 4.6C and 4.7C).  Further, we show that in addition to inhibiting cell division by 
silencing expression of the septal ring protein, FtsZ, DicF also inhibits growth of E. coli 
cells (Fig. 4.8).  Both DicF and DicB are toxic to E. coli.  When expressed from their 
native locus with a heterologous promoter, expression of both genes is severely growth 
inhibitory to E. coli, whereas expression of either gene alone partly relieves this growth 
inhibition (Fig. 4.9).  
From our RNA-Seq analyses, we observed differential expression of a wide array 
of genes in response to DicF.  The functions of these genes ranged from cell division to 
sugar transporters.  The physiological significance of DicF regulating xylR, pykA and 
pfkA is still unclear.   However, it is evident from our RNA-Seq data and fusion analyses 
that DicF heavily modulates the host metabolism, presumably to cause severe toxicity to 
E. coli.  The exact mechanisms by which it causes toxicity are currently unknown and are 
beyond the scope of this study.  Perhaps, further exploration of the DicF regulon could 
shed light into this mechanism.   
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Our microscopy experiments indicated that overproduction of DicF led to 
extensive filamentation and additionally caused the cells to bloat (Fig. 4.8E).  However, 
when the dicF3 mutant was expressed, cells solely filamented without signs of abnormal 
distended morphologies (Fig. 4.8E).  Cells producing DicF3 were not as severely growth 
inhibited as cells expressing wild-type DicF (Fig. 4.8C).  This result suggested that DicF 
might potentially target structural elements of the cell.  For example, disruptions of the 
mre genes encoding proteins that are involved in appropriate chromosomal segregation 
and maintanence of the rod-shape have been shown to exhibit the similar elongated and 
bloated morphology of cells expressing DicF [142].  Chromosome segregation and cell 
division are tightly linked processes, and thus, it would not be surprising if DicF targets 
genes in these closely related essential processes.  
We demonstrate that DicF requires the RNA chaperone Hfq to regulate xylR, 
pykA and pfkA.  Earlier, we demonstrated that Hfq is necessary for SgrS-mediated 
regulation of ptsG (Chapter 3).  Many well-characterized E. coli sRNAs require Hfq for 
their stability and for their effective base pairing to targets.  The fact that this prophage 
encoded sRNA also requires the host chaperone suggests that this sRNA and the host 
have co-evolved to provide an environment where DicF can function optimally.  
Interestingly, although Hfq seems vital for DicF-mediated regulation of targets, it binds 
poorly with DicF compared to its affinity towards other core sRNAs [98].   
There are other examples of sRNAs encoded on foreign DNA elements.  The 
InvR sRNA is encoded on the horizontally acquired SPI-1 of Salmonella [106].  This 
sRNA represses expression of the host abundant outer membrane porin called 
OmpD[106].  Similar to DicF, InvR also requires Hfq for its base pairing properties[106].  
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The IpeX sRNA was discovered in much the same way that DicF was first found [22].  
Multipcopy plasmids containing this sRNA locus conferred regulation of the ompC and 
ompF genes coding for two other outer membrane proteins.  Interestingly, this sRNA is 
present on the Qsr’ cryptic prophage in E. coli.  The IpeX sRNA also requires Hfq for its 
stability and regulatory properties [22].  In sum, the two other known sRNAs encoded on 
horizontally acquired genomic elements seem to require Hfq for their function, 
suggesting that such interactions between the host and these ancient fossil DNA elements 
are not uncommon.   
We observed in Fig. 4.9, that DicF and DicB are both independently toxic to cell.  
Expressed together, their effects are compounded, potentially causing cell lysis (as 
observed by the drop in optical density of the cultures, Fig. 4.9).  Expression of the ΔdicF 
mutant in an otherwise wild-type operon also led to a drop in the OD600 of cultures.  This 
result suggested that DicB could potentially cause lysis of cells when expressed 
continuously for a period of time.  Whether DicB simply inhibits cell division (that 
eventually causes lysis) or has other deleterious effects on the cell is yet to be elucidated.   
The toxicity conferred by the dicBF operon to E. coli cells is evident from this 
chapter.  The Qin prophage is a lambdoid prophage that is only about 20kb, 
approximately half the size of lambda phage.  Qin is a truly defective phage in that it 
lacks several structural elements, the integrase and exicision genes required for 
production of live phage particles .  Given that the dicBF operon is deleterious for E. coli, 
why is this operon retained in E. coli K12 and several E. coli and shigella species?  A 
recent study conducted on cryptic prophages revealed a few surprising findings that may 
potential shed light on this question [152].  In this study, several cryptic prophages in E. 
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coli were shown to promote cell survival during adverse environmental conditions.  The 
Qin prophage and specifically DicB were shown to increase resistance of E. coli to 
certain β-lactam antibiotics [152].  The prediction here was that expression of these toxic 
substances during antibiotic treatments inhibits growth of cells transiently.  Since β-
lactams only act on actively dividing cells, cells expressing these toxins temporarily 
“escape” from the effects of the antibiotics, until the substance is passively diffused into 
the environment [152].  Another possibility for E. coli strains to retain the dicBF operon 
is to use this operon as a means to prevent superinfection by other phages.  Often, when 
temperate phages form lysogens, they carry the means to prevent superinfection by 
further phages [56, 73] and therefore provide immunity to the bacteria they inhabit.  
Along the same line is the notion that some phage-encoded genes contain proteins that 
actually kill the host during superinfection by another phage.  In the latter case, killing of 
the infected host is believed to be an altruistic behaviour, as the lysogen kills the host 
prematurely (and hence its propogation) in order to prevent the incoming phage from 
undergoing the infection cycle, thus contributing to the survival of the population [104].  
Studying interactions between the sRNA DicF and its host demonstrate intruiguing 
aspects of DicF regulatory networks and illuminate important aspects of phage-host 
relationships. 
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4.4. Tables and Figures 
Gene Function 
xylR activator of the xylose catabolism operon  
rbsC D-ribose transporter subunit  
glpK glycerol kinase  
pfkA glycolytic enzyme catalyzing fructose-6-p to fructose 1,6-p  
manX mannose and glucose transport  
rbsA Ribose ABC transporter  
ptsP The EI enzyme of the nitrogen phosphotransferase system  
carB Carbomyl phosphatase synthase (pyrimidine biosynthesis)  
rlmn Dual-specificity 23s rRNA  
pgaA PGA secretion, outermembrane porin  
ppk polyphosphate kinase, component of RNA degradosome  
mtr A tryprophan transporter in E. coli  
psiE Induced during phosphate starvation  
clcA member of the chloride carrier/channel (ClC) family  
pykA Pyruvate kinase  
Gene Function  
bglJ bgl operon transcriptional activator 
rbsD Cytoplasmic protein involved in ribose utilization  
glmS Catalyzes first step of hexosamine biosynthesis  
pykA pyruvate kinase  
cyo operon Subunits of the cytochrome oxidase enzyme of the electron 
transport chain  
nuo operon Subunits of the NADH dehydrogenase enzyme of the electon 
transport chain  
csrB small RNA involved in carbohydrate and glycogen 
metabolism  
glmZ small RNA that regulates glmS synthesis  
 
Table 4.1. The Predicted targets of DicF.  First, the computational programs, Target 
RNA, Copra RNA and Starpicker were used to generate a list of DicF targets.  Genes 
predicted by at least two programs and those with a p-value ≤ 0.05 were chosen for this 
study. Second, genes involved in sugar uptake and central metabolism from RNA-Seq 
analyses of DicF overexpression. 
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Figure 4.1. The genes pykA, xylR and pykA are post-transcriptionally regulated by 
DicF.  A) Translational lacZ fusions of the predicted targets from Table 1 were created 
on the E. coli chromosome.  The general arrangement of the constructs is shown in the 
cartoon.  The fusions either contained an inducible PBAD  promoter or a constitutive Cp19  
promoter, followed by the untranslated region (5′ UTR) of the gene and 10 or 20 amino 
acids of the coding sequence of the gene (CDS).  B) The various fusions were assayed for 
β-galactosidase activity during DicF overexpression.  The specific activities in miller 
units were normalized to the vector control of the corresponding strain to yield the 
relative activity.  The targets chosen to be studied further (indicated by square) were at 
least 2-fold negatively regulated by DicF or 1.75-fold positively regulated by DicF.  
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Figure 4.2. xylR, pfkA and pykA are post-transcriptionally regulated even in the 
absence of the chromosomal Qin prophage.  β-galactosidase activity of xylR, pfkA and 
pykA by DicF was assayed in the presence and absence of chromosomal qin. The specific 
activities in miller units were normalized to the vector control of the corresponding strain 
to yield the relative activity. 
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Figure 4.3. Genetic and molecular characterization of DicF-xylR and DicF-ftsZ  
interactions.  A)  The predicted base pairing region between DicF-xylR and DicF-ftsZ is 
shown. Regions of predicted interactions are indicated by lines.  The RBS and the start 
codon of ftsZ and xylR are indicated on the respective sequences.  The dicF3 and dicF9 
mutations are shown by boxes.  B) β-galactosidase activity of the xylR′ and ftsZ′ fusions 
were assayed in the presence of the various dicF mutants from A as described in Fig. 
4.1B .  C) The predicted base pairing sequences of DicF-ftsZ interactions is shown.  The 
various dicF and ftsZ mutations used to abolish this interactions is indicated.  The ftsZ15 
mutant is compensatory mutation to restore regulation of the dicF15 mutation.   D) β-
galactosidase activity of the ftsZ′ fusion was assayed in the presence of the various dicF 
mutants from C as described in Fig. 4.1B. E) β-galactosidase activity of the ftsZ′ and the 
ftsZ15′ compensatory fusions were assayed in the presence of the various dicF mutants 
from C as described in Fig. 4.4.1B. F) The predicted base pairing sequences of DicF-xylR 
interactions is shown.  The various dicF and xylR mutations used to abolish this 
interaction is indicated.  The xylR3trunc′ fusion only contains one amino acid of the xylR 
CDS.  The xylRcomp11′ mutation was predicted to compensate loss of xylR regulation by 
DicF11. G) β-galactosidase activity of the xylR′, xylR3trunc′ and the xylRcomp11′ 
compensatory fusions were assayed in the presence of the various dicF mutants from C as 
described in Fig. 4.1B. 
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Figure 4.4. Role of host accessory proteins in xylR regulation. A) β-galactosidase 
activity of xylR′-′ lacZ was assayed in a wild-type context and in Δhfq and rne131 
backgrounds.  The specific activities in miller units were normalized to the vector control 
as described in Fig. 4.1A.  B)  A ΔdicF lacIq strain with a Cp19-promoter before xylR 
harboring either the vector control of Plac-dicF  were grown to an OD600 of ~0.1.  RNA 
was harvested at the 0 minute time point.  IPTG was added to induce expression of DicF 
or vector and total RNA was extracted at the time points indicated in the figure.  The 
RNA was then subjected to Northern blot analyses probing for xylR and then for the 
loading control, ssrA.  
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Figure 4.5.  Physiological consequences of DicF-xylR interactions. A  ΔdicF lacIq 
strain harboring the Plac-vector or  Plac-dicF, dicF3 or dicF9 were streaked on LB agar 
plates or M63 xylose plates with and without 0.5mM IPTG. LB plates were incubated at 
37˚C for 12 hours and M63 xylose plates for 22 hours.  
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Figure 4.6. Characterization of pfkA-DicF interactions.  A) Predicted base pairing 
region between DicF and pfkA is shown. B) β-galactosidase activity of pfkA′-′ lacZ and 
pfkA8′-′ lacZ was assayed in the presence of DicF and DicF8. C) β-galactosidase activity 
of pfkA′-′ lacZ was assayed in a wild-type context and in a Δhfq and rne131 mutant 
background. The specific activities in miller units were normalized as described in Fig. 
4.1B.  D)  A ΔdicF lacIq strain harboring the vector control or Plac-dicF were grown to an 
OD600 of ~0.1.  RNA was harvested at the 0 minute time point.  IPTG was added to 
induce expression of DicF or vector and total RNA was extracted 20 minutes after 
induction.  The RNA was then subjected to Northern blot analyses probing for pfkA and 
then for the loading control, ssrA.   
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Figure 4.7. Characterization of  pykA-DicF interactions.  A) Predicted base pairing 
region between DicF and pykA is indicated. The RBS and the start codon of the pykA 
mRNA are shown on pfkA. B) Mutational analyses of DicF-pfkA interactions. C) β-
galactosidase activity of pykA′-′ lacZ  was assayed in a wild-type context and in a Δhfq 
and rne131 mutant background. The specific activities in miller units were normalized as 
described in Fig. 4.1B.  D)  A ΔdicF lacIq strain harboring the vector control or Plac-dicF 
were grown to an OD600 of ~0.1.  RNA was harvested at the 0 minute time point.  IPTG 
was added to induce expression of DicF or vector and total RNA was extracted at time 
time points shown.  The RNA was then subjected to Northern blot analyses probing for 
pykA and then for the loading control, ssrA.  
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Figure 4.8. DicF inhibits cell division and impairs growth of E. coli cells. A) β-
galactosidase activity of xylR′-′lacZ, ftsZ′-′lacZ, pykA′-′ lacZ and pfkA′-′lacZ  were 
assayed in the presence of vector control, DicF, DicF3 and DicF21 mutants expressed 
from a Plac-plasmid. The specific activities in miller units were normalized as described in 
Fig. 4.1B. B) A ΔdicF lacIq strain harboring the vector control or Plac-dicF,dicF3 or 
dicF21 alleles were streaked out in LB agar plates with antibiotics only (-IPTG) and with 
antibiotics and IPTG (+IPTG).  Plates were incubated for 10 hours at 37˚C for 10 hours. 
C) The same strains described in B were subcultured from overnight cultures into fresh 
LB medium containing ampicillin.  Cultures were grown until cells carrying the vector 
control reached an OD600 of ~ 0.1 and IPTG was added to all cultures.  Growth of the 
different strains was monitored over time. These results are results from 3 technical 
replicates. D) 1ml of cultures carrying the strains described in B and C were removed at 
the time points indicated by the asterisk, washed, serially diluted and plated on LB 
antibiotics plates without inducer.  The CFU/ml was then calculated after 12 hours of 
incubation.  The “IPTG-” CFUs/ml were measured before the addition of IPTG indicated 
by the asterisk in C.  the “IPTG+” CFUs/ml were measured at the very last time point 
after the addition of IPTG as shown by the asterisk in C. E) The strains described in B 
were grown in LB with antibiotics for 1 hour and cells expressing the four plasmid 
constructs were imaged (-IPTG).  IPTG was added after this and cultures were grown for 
20 minutes and 60 minutes respectively and were once again imaged.  Five different 
images were taken per strain per time point.  The image shown is representative of the 
five sample images taken.   
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Figure 4.9. (cont.) 
 
Figure 4.9. DicF and DicB act in synergy to cause toxicity to E. coli. A) The four 
constructs used in this figure are illustrated. Construct 1 was made by replacing the native 
promoter of the dicBF operon with an inducible  Plac-promoter in E. coli. In the context of 
this strain, strain 2 was constructed by deleting the entire dicF sRNA and replacing it 
with a scar sequence as described in materials and methods.  Similarly, strain 3 was made 
by deleting dicB and strain 4 contained both dicF and dicB deletions.  B) The four strains 
described in A were grown were streaked on LB agar plates with and without IPTG and 
incubated for 12 hours at 37˚C.  C) A wild-type DJ480 strain containing the native dicBF 
promoter and the four strains described in A were growth with the inducer IPTG upon 
sub-culture from an overnight culture in LB medium.  Growth of the strains was 
monitored over time.   
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Chapter 5: Small RNA binding-site multiplicity involved in translational regulation 
of a polycistronic mRNA 
5.1. Introduction 
In many eukaryotic organisms, small interfering RNAs (siRNAs) and microRNAs 
(miRNAs) control gene expression at the post-transcriptional level in diverse pathways 
[50, 51, 105]. In bacteria, small RNAs (sRNAs) similarly control gene expression post-
transcriptionally and the principles (if not the details) of sRNA regulatory mechanisms 
have much in common with miRNA and siRNA regulation (discussed in detail in section 
1.1.1).  Like miRNAs, many bacterial sRNAs function by base pairing with mRNA 
targets to affect their translation and stability.   
 Two targets of the sRNA SgrS include the ptsG and manXYZ mRNAs, which 
encode sugar transporters of the PTS.  SgrS inhibits translation and promotes degradation 
of both of these mRNAs [64, 115, 139].  The molecular mechanisms by which sRNAs 
regulate their target mRNAs are of considerable interest, and studies continue to identify 
new intricacies of translational and stability control.    SgrS base pairs with sequences of 
the ptsG mRNA RBS and inhibits ribosome binding directly.  This translational 
repression is concomitant with, but does not require RNase E-mediated degradation [95].  
A study from our laboratory described SgrS-dependent regulation of the manXYZ mRNA. 
We established that SgrS base pairs with sequences in the coding region of manX to 
inhibit translation. The SgrS-manX interaction stimulates degradation of the manXYZ 
message by the RNase E degradosome; however, as with ptsG, translational repression of 
manX does not require degradation [115].  It was hypothesized that manY and manZ 
translation would be regulated indirectly by SgrS as a result of the SgrS-dependent 
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degradation of manXYZ mRNA. Contrary to this hypothesis, Dr. Jennifer Rice in our 
laboratory discovered that manY and manZ were regulated by SgrS, independently of 
manX regulation.  She discovered that SgrS base pairs with sequences at a second site on 
the manXYZ polycistronic mRNA. The second base pairing interaction involved 
sequences in the manX-manY intergenic region, and this interaction allows SgrS to 
repress translation of manY by a mechanism that is independent of manX translational 
regulation.  Using genetic and biochemical analyses, Dr. Rice established that SgrS base 
pairs in the CDS of manX and in the intergenic region of manXY to repress translation of 
manXYZ.   
 In this chapter, we characterize the significance of SgrS pairing at two sites on the 
manXYZ polycistron.  We show that base pairing of SgrS at manX and manY are 
necessary for degradation of the entire operon.  Moreover, pairing at both sites is required 
for SgrS-mediated rescue of E. coli cells from glucose-phosphate stress.   
5.2. Results 
 Dr. Rice’s genetic analyses indicated that distinct sgrS base pairing residues 
interacted with manX versus manY.  Subsequently, the SgrS-insenstive manXGUG and 
manYS1 mutants were isolated.   
5.2.1. SgrS pairing at two sites on manXYZ is required to destabilize the manXYZ 
mRNA 
The data shown by Dr. Rice [115] demonstrate the existence of two SgrS binding 
sites on the manXYZ mRNA.  In mammalian systems, miRNAs often recognize  multiple 
binding sites on a single mRNA target, and multiple binding events act cooperatively to 
achieve maximal translational regulation of the target[71, 123, 132, 154].  For SgrS 
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regulation of manXYZ, we did not see evidence of cooperativity for translational 
regulation.  Binding at the manX site alone (in the absence of the manX-manY intergenic 
site) allows translational regulation of manX [115], while binding at the manX-manY 
intergenic site alone (when the manX site is mutated) allows regulation of manY 
translation.  Despite the sufficiency of each individual target site for translational 
regulation of the cognate gene(s), we reasoned that multiple binding sites might 
cooperate with respect to SgrS-promoted degradation of the full-length manXYZ mRNA.  
We investigated this possibility by incorporating mutations that abrogated SgrS pairing at 
either the manX site (manXGUGYZ), the manX-manY intergenic site (manXYS1Z) or both 
(manXGUGYS1Z).  These alleles were moved to the chromosomal manXYZ locus, and 
levels of manXYZ mRNA were monitored by quantitative Real Time PCR (qRT-PCR) 
before and after stress.  Levels of mRNA after stress were normalized to levels before 
stress.  In a strain lacking sgrS, manXYZ levels increased slightly following stress (to 
~1.3-fold relative to pre-stress levels) (Fig. 5.1A).  This result was expected, as a 
previous study using Northern blots demonstrated that manXYZ mRNA levels increase in 
stressed cells in the absence of SgrS [115].  In cells producing wild-type SgrS and 
manXYZ mRNA, levels of the manXYZ mRNA were reduced to approximately one-third 
the pre-stress levels (Fig. 5.1A).  Levels of mutant mRNAs that only contained one of the 
SgrS binding sites (manXGUGYZ and manXYS1Z) remained unchanged upon stress (Fig. 
5.1A).  This result suggested that pairing at only one of the two SgrS sites is not 
sufficient to permit SgrS-dependent degradation of the manXYZ transcript.  When both 
binding sites were disrupted, i.e., in cells with manXGUGYS1Z, we again saw slight 
accumulation of the manXYZ mRNA (~1.3-fold increased) after stress.  In sum, while 
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binding at an individual site permits SgrS to translationally regulate the appropriate gene, 
binding at both sites is required to allow degradation of the manXYZ mRNA. 
5.2.2. In vivo relevance of binding site multiplicity  
Thus far, we have shown that SgrS binding at each of the two target sites 
regulates translation of manX and manYZ independently and that both target sites are 
required for regulation of manXYZ stability.  To assess the impact of multiple binding 
sites on the physiology of cells growing under stress conditions, we examined growth of 
cells that were stressed by exposure to the glucose analog 2-deoxyglucose (2DG).  We 
showed previously that exposure of cells to 2DG causes induction of the glucose-
phosphate stress response and that ManXYZ is responsible for transporting this stress-
inducing molecule [115].  We hypothesized that SgrS-promoted degradation of the 
manXYZ mRNA would make the regulation more efficient or stringent, and that this 
would be important for an effective stress response and growth recovery in the presence 
of 2DG.  Strains with wild-type or mutant sgrS and manXYZ alleles were grown on 
minimal media with fructose as the carbon source with or without 2DG.  In the absence 
of stress, all strains grow similarly on this medium (Fig. 5.2).  When cells were stressed 
with 2DG, the strain carrying chromosomal copies of wild-type sgrS and wild-type 
manXYZ (WT sgrS WT manXYZ, Fig. 5.2) and the strain lacking manXYZ (WT sgrS 
manXYZ ,Fig. 5.2) both grew well and formed single colonies.  In contrast, cells 
expressing manXYZ but lacking sgrS failed to grow, even in the zone of heaviest 
inoculation (sgrS WT manXYZ, Fig. 5.2).  These data are consistent with previous 
observations that ManXYZ is the primary transporter for 2DG and when its production is 
reduced via SgrS-mediated post-transcriptional repression or eliminated by manXYZ 
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deletion, cells are able to recover from stress [115].  We next tested growth of two 
different strains that allowed us to discern whether regulation via SgrS base pairing at 
only the manX site was sufficient to provide stress relief.  The strain carrying the sgrS1 
allele and wild-type manXYZ showed a growth phenotype intermediate between those of 
wild-type and sgrS strains (sgrS1 WT manXYZ, Fig. 5.2).  Since SgrS1 regulates manX 
but not manY translation, this result suggests that regulation of manX translation alone is 
not sufficient to promote maximal recovery from stress.  In support of this idea, we 
observed the same defective growth phenotype in the strain where regulation of manY by 
SgrS was prevented by the manYS1 mutation (WT sgrS manXYS1Z, Fig. 5.2).  Taken 
together, these results suggest that while pairing of SgrS at one of the two binding sites 
on the manXYZ mRNA provides some relief from stress, base pairing at both the sites is 
required for maximally efficient repression of ManXYZ synthesis and subsequent full 
recovery of cells from stress.  
5.3. Discussion 
  This chapter is congruent with a model in which SgrS regulation of manXYZ 
occurs by base pairing at two sites on the manXYZ transcript, as illustrated in Fig. 5.3, 
Interactions of SgrS with a site in the manX coding region and another in the manX–
manY intergenic region cause translational repression of manX and manY-manZ, 
respectively.  Although pairing at each site individually is sufficient for translational 
regulation of the cognate genes, individual pairing interactions do not promote significant 
RNase E-dependent manXYZ mRNA degradation.  Rather, pairing at both sites appears to 
be a prerequisite for inducing mRNA degradation.  Further, although pairing at a single 
site provides sufficient regulation to allow partial recovery from GP stress, pairing at both 
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sites apparently enhances the efficiency of regulation in a way that facilitates better 
recovery of cells from stress.  
  In the case of SgrS regulation of manXYZ mRNA, the mechanistic rationale for 
the two-binding-site requirement may be related to the translational architecture of the 
mRNA.  The manX and manY genes have independent translation initiation signals and 
manZ translation is coupled to that of manY.  SgrS pairing at the manX site alone would 
not immediately impact manY and manZ translation, and vice versa, regulation at the 
manX-manY intergenic site alone would not impact manX translation.  It seems likely that 
continued translation of portions of the transcript would impede RNase E-mediated 
degradation of the full-length mRNA, and slow the kinetics of regulation.  This model is 
consistent with the qRT-PCR data (Fig. 5.1A) showing that there is no significant 
reduction of mRNA levels when either pairing site is inactivated by mutation.   
Hfq associates with the C-terminal scaffold region of RNase E, and this 
association is thought to help recruit RNase E to sRNA–mRNA duplexes (31).  However, 
not all Hfq-dependent sRNA–mRNA duplexes are targeted for degradation, so other 
factors must modulate the efficiency of RNase E recruitment or the accessibility of 
RNase E cleavage sites. The experiment shown in Fig. 5.1B suggests that the role of the 
manX– manY intergenic SgrS pairing site is more than simply inhibiting manY–manZ 
translation to unmask RNase E-sensitive sites. Perhaps the nature of Hfq interactions with 
manXYZ mRNA dictates binding at both sites for efficient Hfq-mediated recruitment of 
RNase E. More work is needed to elucidate the properties of sRNA–mRNA 
ribonucleoprotein complexes that determine the RNAs’ stability. 
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There are a number of examples where bacterial sRNAs mediate discoordinate 
regulation of polycistronic transcripts.  For example, Spot42 targets the galETKM mRNA 
and inhibits galK translation, but does not affect expression of galET or stability of the 
mRNA [91].  RyhB selectively inhibits translation of iscS in the iscRSUA operon and 
promotes degradation of the iscSUA portion of the transcript, while iscR mRNA is stable 
[29].  Positive discoordinate regulation has also been described.  The pldB-yigL mRNA is 
processed in an RNase E-dependent manner, yielding a 'pldB-yigL mRNA that is targeted 
for stabilization by SgrS [102].  There are certainly hints from transcriptome studies that 
bacterial sRNAs commonly target entire operons for coordinate up or down-regulation 
[83, 126].  We predict that in at least some of these cases, sRNAs will use multiple 
binding sites to accomplish such coordinate regulation of genes encoded on polycistronic 
mRNAs.  In fact, there is evidence implying sRNA binding site multiplicity for 
regulation of the opp3BCDFA mRNA in Staphylococcus aureus.  The S. aureus sRNA 
RsaE was identified in a study by Geissmann, et al. [40], which showed that in the 
absence of rsaE, levels of many mRNAs encoding nutrient transport and metabolism 
functions were altered.  While RsaE was demonstrated to directly pair with sequences in 
the RBS of the first gene in the operon, oppB, a later study by Bohn, et al [12] also 
predicted pairing with opp3A, the distal gene in the operon.  This group demonstrated that 
RsaE inhibits opp3A translation in vitro, although the specific pairing determinants were 
not elucidated.  Together, these two studies provide evidence that the opp3 mRNA 
contains at least two binding sites for the RsaE sRNA.  More detailed studies regarding 
the molecular mechanisms governing this regulation are required to determine how this 
affects production of the proteins encoded by the mRNA, and what the physiological role 
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for this regulation may be.  There are likely to be some interesting differences between 
this case and SgrS-manXYZ, since S. aureus sRNAs do not appear to require Hfq and the 
data thus far suggest that RsaE does not affect opp3 mRNA levels [12, 40]. 
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5.4. Figures 
 
 
Figure 5.1. Pairing of SgrS at both sites on the manXYZ mRNA is required for 
maximum manXYZ degradation.  Cells containing the Cp19-manXYZ (JH124, Cp19-
manXGUGYZ (JH341), Cp19-manXYS1Z (JHDB05) and CP19-manXGUGYS1Z (JHDB07) 
fusions in wild-type sgrS
+
 backgrounds and the Cp19-manXYZ fusion in a ΔsgrS 
background (JH125) were grown to mid-log phase and total RNA was extracted from 
cultures (-αMG). Cells were then treated with 0.5% αMG and total RNA extracted 30’ 
following αMG addition (+αMG). RNA was DNase-treated, reverse transcribed and the 
cDNA subjected to quantitative Real-Time PCR using manX-specific primers. Levels of 
the manXYZ transcripts from each of the fusion backgrounds +αMG treatment were 
calculated relative to the –αMG RNA samples.  
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Figure  5.2.  Pairing of SgrS at both sites on the manXYZ mRNA is required for 
maximum relief from stress.  Strains with wild-type sgrS and manXYZ (DJ480), ΔsgrS 
and wild-type manXYZ (CS104), sgrS1 and wild-type manXYZ (CS123), wild-type sgrS 
and manXYS1Z (JHDB01) and wild-type sgrS and ΔmanXYZ (YS208) were plated on 
minimal M63 fructose medium without 0.5% 2DG.  
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Figure 5.3. The SgrS-manXYZ regulatory mechanism.  The data presented are consistent with 
the model shown.  SgrS binds to sites in the manX coding sequence and the manX-manY 
intergenic region to inhibit translation of manX and manYZ, respectively.  Both interactions are 
required to efficiently promote RNase E-mediated degradation of the manXYZ mRNA.  
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Chapter 6: Conclusions and future directions 
Regulatory sRNAs in eukaryotic and bacterial species play critical roles in post-
transcriptional regulation of gene expression.  While they were serendipitously identified 
in the late 1980s in bacteria, the roles of these RNA regulators in bacterial physiology are 
still pooly understood.  In addition, the multitudes of mechanisms by which sRNAs 
regulate their targets are just beginning to be uncovered.  In this dissertation, we use two 
sRNAs to study mechanistic and physiological implications of the complex regulatory 
networks mediated by regulatory RNAs.    
SgrS is a sRNA found in many enteric bacterial species that helps bacterial cells 
recover from sugar-phosphate stress (a stress caused by accumulation of phosphorylated 
sugars) primarily by silencing expression of sugar transporters (such as ptsG and 
manXYZ) that import the stress [115]. Regulation of the ptsG mRNA is achieved via a 
canonical mechanism in which SgrS binds to the RBS of ptsG, repressing its translation 
[77, 78].  In contrast, SgrS regulation of manX is not typical.  A previous study 
demonstrated that SgrS binds in the CDS of manX, silencing its translation [115].  In 
chapter 5 of this dissertation, we showed that SgrS regulates manY (the second gene in 
the manXYZ operon) in addition to manX.  This repression is crucial for degradation of 
the entire manXYZ mRNA and is important for recovery of E. coli cells from sugar-
phosphate stress.  SgrS, thus, co-ordinately regulates three genes in an operon in order to 
obtain maximal relief from stress.   The mechanism by which SgrS represses manX and 
manY translation is still unclear.  Future directions on this project include studying how 
SgrS regulates the manX and manY genes independently although it binds away from the 
translation initiation region of both genes.  Further, it will also be useful to characterize 
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why SgrS pairing at two sites on the operon is required for manXYZ degradation.  
Perhaps, there are mechanistic details of RNase E recruitment to this operon that are yet 
to be elucidated.   
SgrS is also a unique bacterial sRNA in that it has two functions.  In addition to 
regulating targets via its RNA base pairing function, SgrS also encodes the peptide 
SgrT[146] .  While these two functions are individually well characterized, this study is 
the first to describe the interactions between the base pairing and SgrT functions of SgrS.  
In chapter 3, we demonstrated that mutations in the translation initiation sequences of 
sgrT have little effect on the SgrS base pairing function, whereas mutating the base 
pairing region of sgrS increases SgrT production.  Moreover, we discovered that the SgrS 
base pairing function precedes SgrT production when Salmonella cells are exposed to 
stress.  This work proposes a model in which the base pairing function acts to prevent 
new PtsG synthesis and SgrT acts on pre-existing PtsG transporters to inhibit the entry of 
stress molecules.  Thus, in this dissertation, we have identified a unique mechanism by 
which a dual-function sRNA achieves its physiological goal by directing both its 
regulatory functions towards the same goal, but at different stages of the stress response.  
While the physiological role of SgrS has been characterized in detail by multiple 
studies [119, 120, 139], the various targets and cellular roles of the sRNA DicF is still at 
its infancy.  The sRNA DicF is encoded on the Qin prophage in E. coli.  Even though 
DicF was one of the first discovered sRNAs, its only target is the ftsZ mRNA, whose 
product is essential for cell division [133]. In order to understand how DicF and the 
prophage might be interacting with the host E. coli genome, we used computational and 
RNA-Seq analyses to identify three host targets of DicF (Chapter 4).  The targets xylR, 
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pykA and pfkA encode enzymes in metabolism.  We demonstrated that DicF not only 
inhibits cell division, but also has other unknown toxic properties.  Further, both DicF 
and DicB act synergistically to inhibit host cell division and cause lysis of E. coli cells.  
Several aspects of this sRNA are yet to be studied.  We have only uncovered three 
targets of DicF.  RNA-Seq analyses revealed a myriad of genes that were expressed 
differentially in response to DicF.  Careful analyzation of targets from these experiments 
and co-relating the target functions to phenotypes conferred by DicF is crucial to 
understanding its toxic effects.  Similarly, DicB is also toxic and potentially lethal for 
cells when expressed over a long period of time.  Identifying the cellular targets of DicB 
would be useful in elucidating the overall deleterious effects of the dicBF operon to E. 
coli cells.   
Some basic physiological questions about the nature of the operon are still 
unclear.  For example, is this operon unique to the Qin prophage? Towards this question, 
finding an active prophage that contains DicF-like sequences, and observing phenotypes 
conferred by induction of this active prophage may be useful.  Further, introspection of 
the potential benefits of this operon and/or prophage to host fitness is also required to 
understand why elements of this prophage are still retained by E. coli.  Some possible 
beneficial aspects of having this prophage include increased resistance to adverse 
environments as suggested earlier [152] and prevention of superinfection by other 
phages.  Third, identification of environmental triggers that stimulate the expression of 
the dicBF operon is also necessary.     
The two sRNAs in this dissertation are exemplary examples of the slew of 
mechanisms employed by sRNAs to regulate targets.  SgrS uses its base pairing 
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properties and its mRNA function at different stages of sugar-phosphate stress response.  
It also regulates multiple genes in an operon leading to their more effective degradation, 
and thus provides maximal stress relief to cells.  DicF, encoded on a prophage, uses 
unique mechanisms to regulate cell division and modulate host metabolism. This sRNA 
seems to have a unique and detrimental relationship with the host it inhabits.  
Understanding physiological and mechanistic implications of regulation by bacterial 
sRNAs have revealed astute regulatory networks used by regulatory sRNAs to achieve 
specific functions in the cell.   
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